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Executive summary  
Purpose of the evaluation 
This report provides a summative evaluation of the Development Innovation Fund – Health (DIF-
H). The primary user of this evaluation is the Government of Canada, which by Treasury Board 
decision, required that a retrospective assessment of DIF-H relevance and performance be 
conducted and presented to the Government of Canada after five years of program existence.  
The Development Innovation Fund – Health 
The Government of Canada established the DIF-H in 2008 when it pledged $225 million over five 
years to support breakthrough research on critical global health problems with the aim of bringing 
lasting improvements to the health and lives of people in low-income countries (Government of 
Canada, 2008). 
DIF-H’s main objectives are 
1. Identify and prioritize profound health challenges facing the developing world. 
2. Mobilize scientific communities in Canada and the rest of the world, including the developing 
world, to address these health challenges through competitive selection and funding of 
projects.  
3. Facilitate the affordable implementation and commercialization, in developing regions of the 
world, of solutions that emerge. 
DIF-H is realized through the combined efforts of a consortium made up of the International 
Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR), and 
Grand Challenges Canada (GCC). GCC is the implementing body, and is responsible for 
organizing grant calls and overseeing funded projects. CIHR is responsible for reviewing 
applications in response to GCC grant calls. IDRC is responsible for accountability to the Canadian 
government, disbursing funds to GCC, and managing evaluations and audits of DIF-H. 
Methodology 
A comprehensive evaluation approach was developed, inspired by contribution analysis (Mayne, 
2009), an internationally accepted, theory-based methodology. The evaluation used a mixed-
methods design drawing on multiple sources of data, such as program documents and project 
databases, academic and grey literature, interviews, focus group discussions, field-based case 
studies, and an online survey of both successful and unsuccessful applicants to DIF-H. A range of 
perspectives were considered from DIF-H consortium staff, GCC applicants and grantees, DIF-H 
stakeholders, and external experts. A framework analysis (NatCen Learning, 2012) approach was 
used to triangulate, cross-check, and analyze the results to ensure they were robust and 
sufficiently comprehensive. 
A draft of this report was reviewed by all members of the consortium, an external oversight 
committee, and an independent reviewer contracted by Oxford Policy Management. 
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Findings  
Evidence was assessed with reference to the requirements of the Treasury Board of Canada 
Secretariat. Five core issues were considered, following the Policy on Evaluation (Centre of 
Excellence for Evaluation, 2009), to assess whether the program has demonstrated value for 
money as a Canadian public investment. The Treasury Board of Canada defines value for money 
as the degree to which a program demonstrates relevance and performance (Centre of Excellence 
for Evaluation, 2013). 
Relevance 
Continued need for the program 
Global health continues to be a priority in international development and is highlighted in the 
Sustainable Development Goals (SDGs) as needing further investment. DIF-H addresses 
demonstrable needs for Canada, as well as the international community, and in so doing provides 
a significant contribution to several SDGs (2, 3, 6, 9, and 17). There is a continuing need for 
financing to support innovations while resolving barriers to global health and safety, and promoting 
development and equity in low- and middle-income countries (LMICs). Innovation is recognized as 
a relevant and cost-effective way to address health challenges in LMICs. DIF-H has increased the 
opportunities for Canadian researchers and innovators to engage with LMIC innovators and 
research institutions. This work, supported by DIF-H, has contributed to positioning Canada at the 
forefront of international efforts to rethink development modalities.  
The Canadian public recognizes the importance of this national support for development and 
global health, both from a humanitarian perspective and in terms of reducing the potential dangers 
of global health risks, and appreciates the value it adds to Canada’s international reputation.  
Alignment with government priorities  
Global health is a priority for Canadian official development assistance (ODA), and within that, 
maternal, newborn, and child health is a key priority. DIF-H is aligned with the Department of 
Foreign Affairs, Trade and Development’s Report on Plans and Priorities.   
DIF-H is also broadly aligned with other Canadian government sectors, such as industry and trade 
and the renewed science and technology strategy (Government of Canada, 2015). 
DIF-H supports projects in 54 countries, many of which are classed as priorities for Canadian ODA. 
DIF-H aims to expand relevant innovations developed in these countries to benefit more ODA 
priority countries. 
Alignment with federal roles and responsibilities 
Innovation must be based on good science, yet be adaptive and responsive to local needs. Good 
management is essential in balancing the risks inherent in investing in innovation. By leveraging 
the expertise of all consortium members, DIF-H addresses all these issues and, therefore, the 
consortium mechanism is well suited to managing an innovation fund and providing a funding 
delivery vehicle. 
In the absence of any suitable independent not-for profit organization, the decision to create GCC 
as a new organization within the consortium was also appropriate, and still remains valid.  
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DIF-H offers a valuable contribution to Canada’s diplomatic agenda and GCC has established an 
impressive set of formal and informal international partnerships and networks. However, DIF-H 
lacks a clear strategic vision for coordinating with, and working alongside, the wider governmental 
aid effort. 
Performance 
Achievement of expected outcomes 
Ultimate outcomes have been achieved. DIF-H-funded projects have saved and improved lives 
through innovative interventions. This evaluation estimates that in the region of 8,689 lives have 
been saved (range: 209 to 16,415) and 160,000 lives improved (range: 136,905 to 252,452). 
Intermediate outcomes have been achieved. Around 3.69 million people in developing countries 
(range: 3.69 million to 5.28 million) now have access to innovative health products and services 
developed through DIF-H funding. Projects funded by DIF-H have had a positive impact on health 
policies, training practices, and health systems, improving the lives of end-users. 
Immediate outcomes have been achieved. Around 7,600 jobs and funding opportunities in 
addressing global health through innovation have been created both in Canada (estimated 578) 
and in LMICs (estimated 7,018). An estimated 78% of DIF-H-funded projects were specifically 
developed in response to GCC grant calls, supporting the idea that DIF-H is addressing a market 
gap and, indeed, creating new opportunities, rather than funding adapted or repurposed projects. 
As current investments mature, further beneficial outcomes are expected. 
GCC has successfully promoted organizational and project partnerships, building networks and 
developing capacity in supporting health innovation projects. It has also leveraged and secured 
venture capital funding in excess of the original DIF-H investment. 
These activities have contributed to increased knowledge and awareness of a positive international 
Canadian brand related to global health innovation. Plans to further promote the Canadian 
government’s involvement in DIF-H will further boost Canada’s reputation. 
Outputs have been produced. According to the most recent data available (GCC Annual Report 
2013–2014), 346 innovations have been developed, including prototypes, service delivery models, 
and models developed through economic modelling. Grantees have published results in peer-
reviewed papers and have secured patents for innovations. 
In addition, there is a high success rate in expanding the development of small-scale projects. 
Caution is needed in interpreting this result; it may suggest a conservative approach to funding 
advanced projects with little risk. A more risk-tolerant approach could see the funding of even more 
innovative projects that offer a fresh and novel perspective. 
These are significant accomplishments for a research and innovation program that has only been 
operational for five years. It is our independent assessment that the Government of Canada (by 
action of IDRC, CIHR, and GCC) has demonstrated international leadership in the use of science 
and human creativity to improve the health of those who need it most. 
Still, GCC monitoring of projects and reporting of results requires improvement. These findings 
represent a triangulation of the best available evidence from multiple GCC documents, and primary 
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data independently collected by the evaluators. More precise and reliable presentation of results 
was not possible due to deficiencies and limitations of the GCC monitoring and reporting system. 
These limitations result from attempting to develop a monitoring and reporting system that requires 
minimal effort, can be easily used by grantees, and requires little technical expertise to interpret 
reports. The system is not sufficiently systematic, and indicators need to be strengthened. In 
addition, GCC’s reporting of results requires greater attention to scientific rigour, transparency, and 
consistency. The current approach damages the credibility of claims by allowing skepticism of 
genuine results. 
GCC has improved this system since the formative evaluation, but further work is still needed.  
Demonstration of efficiency and economy 
DIF-H has been an efficient investment for the Government of Canada, in terms of both the results 
achieved in relation to resources utilized (allocative efficiency) and the processes that have 
translated inputs into outputs (operational efficiency).  
The evaluation found that the establishment and implementation of DIF-H was economical, with 
minimization of procurement costs, mechanisms to leverage technical support through networking, 
and restricting inputs to only those that were needed. However, some of the DIF-H economies may 
not actually be net savings for the Government of Canada, because the services provided by CIHR 
and IDRC have been undervalued. The exact funding shortfall incurred by these organizations due 
to insufficient funding allocation is not known because resource outputs assigned to DIF-H were 
not tracked.  
The allocative efficiency of DIF-H is acceptable, especially since more results from current 
investments will be achieved in the future. The findings of this evaluation provide benchmark data 
for future assessments of the DIF-H or similar programs.  
The operational efficiency of DIF-H is good, but there is room for improvement. DIF-H and GCC 
compare well to international benchmarks, but it appears that GCC underinvests in its own 
operations. Efficiency could be increased, for example, by hiring more specialist staff to improve 
the rigour of monitoring and evaluation. While DIF-H’s management and reviewing practices are 
good, internal knowledge transfer throughout the consortium has at times been inefficient. 
All DIF-H consortium members performed their specified roles proficiently. DIF-H is adequately 
directed by the GCC board, which includes representatives from IDRC and CIHR. However, 
current governance mechanisms do not provide the Government of Canada with a system to 
proactively steer DIF-H activities, which renders the government vulnerable to risks that it has no 
ability to mitigate.  
The evaluators note that there has been limited scientific input throughout project life cycles and in 
relation to recent DIF-H management decisions. This means that opportunities to guide program 
developments scientifically have been missed and the scientific rigour of projects cannot be 
guaranteed. 
Conclusions and recommendations 
The Government of Canada’s investment in DIF-H has provided value for money. Investing 
in DIF-H remains relevant, and DIF-H has produced significant results. These outcomes 
have been produced economically, with acceptable levels of allocative efficiency and good 
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levels of operational efficiency. Still, this evaluation has uncovered several issues that 
require attention.  
If further investment is allocated to DIF-H in its current form, a key consideration will be 
determining the extent to which the Government of Canada wishes to steer the strategic direction 
of these funds. As the financing of GCC by external sources increases and its accountabilities 
diversify, the Canadian government’s stewardship influence will be weakened. However, 
increasing government control risks undermining the purposes for which GCC was created: 
independence, flexibility, and responsiveness.  
Regardless of the future form that DIF-H takes, the following recommendations are presented to 
improve program relevance and performance. 
Recommendation 1: Better strategy. DIF-H should develop an applied and dynamic, consortia-
level strategy for outlining coordination with Canadian aid and other governmental initiatives in 
global health and development. A DIF-H strategy should also formalize expected visibility 
arrangements and improve internal knowledge transfer and cooperation between consortium 
members. The same is recommended of any DIF endeavour into other fields of innovation (e.g., 
environment, agriculture, education, etc.). 
Recommendation 2: Strengthen scientific oversight. Although CIHR peer review ensures that 
funded projects are scientifically rigorous at their earliest stages, there are few mechanisms to 
ensure that scientific standards of projects are maintained post-implementation. Mechanisms 
should be put in place to guarantee the scientific integrity of funded projects throughout their life 
cycle. While the Scientific Advisory Board does review the outcomes of the top performing projects, 
it is afforded insufficient time and data, and it lacks sufficient resources and mandate to do this for 
all projects. Therefore a more systematic, but efficient, mechanism is needed. GCC’s formation of 
specialist platforms to support the targeted challenge and Transition to Scale grand challenges is a 
step in the right direction, but GCC should pay greater attention to the Stars projects. 
The decision that the Scientific Advisory Board should work through subcommittees has resulted in 
reduced scientific leadership and input. Accordingly, opportunities were missed for engagement 
with the strategic direction of GCC and DIF-H (as opposed to the operational work of the individual 
grand challenges). DIF-H must consider these implications and work to ensure that management 
decisions continue to be supported by expert scientific thinking. 
Recommendation 3: Optimize metrics. The results indicators used by GCC require further 
refinement to make them more precise and objective. Adopting international measures of efficacy 
that better reflect age-weighted health gains would also enable international comparisons of 
efficiency. The evaluators appreciate that there are advantages and limitations of different 
measurement methodologies, but the use of common metrics and benchmarks could help facilitate 
reporting, and form the basis for target setting.  
Recommendation 4: More rigorous monitoring and reporting. GCC should undertake a 
comprehensive review of its monitoring and reporting arrangements. These need to be more 
systematic, transparent, and consistent, so as to balance the externally facing promotional 
approach with the need for scientific rigour. To ensure credibility, there should be an audit trail 
connecting raw data to final results claims. 
Recommendation 5: Seize efficiency opportunities. GCC is an efficient organization. However, 
further operational investment would increase efficiency to a greater extent and avoid the risk of 
underperformance. Although this represents a trade-off with cost minimization, investment in areas 
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such as more comprehensive monitoring and additional specialist staff could improve results and 
reporting that will balance the allocative efficiency ratio of inputs to outcomes—in simpler terms, 
doing more with more. 
DIF-H should review the funds allocated to IDRC and CIHR to ensure that they cover the actual 
costs incurred in providing services to DIF-H. This allocation should be based on an estimation of 
previous resource use. Future resources provided to DIF-H should be tracked to prevent under- or 
over-allocations. 
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Management response and action plan 
 
Overall, members of the Development Innovation Fund – Health (DIF-H) consortia are satisfied with 
the structure, content, conclusions and recommendations of the Summative Evaluation of DIF-H.   
 
The IDRC endorses the quality of this evaluation report.  The report meets, and in particular areas 
exceeds, accepted standards of: utility, feasibility, propriety, and accuracy.  The DIF-H consortium 
concurs and has taken advantage of multiple opportunities to inform, question, and support the 
external evaluator.  At the same time, concrete and robust steps have ensured absolute independence 
of the evaluation process and result. 
 
Consortium members agree with the evaluators conclusion that DIF-H is a relevant investment for the 
Government of Canada, and that it has met all of its objectives in terms of results achieved in relation 
to inputs. More specifically that: 
• DIF-H addresses demonstrable needs for the international community, Canadian innovators, 
and the public; 
• DIF-H is well aligned with the Government of Canada’s thematic priorities in global health 
development and innovation; 
• The consortium mechanism for DIF-H is relevant for the management of an innovation fund;  
• Reasonable expectation of all ultimate, intermediate and immediate outcomes and outputs 
has been achieved by DIF-H; 
• An acceptable level of economy was achieved by DIF-H. Allocative efficiency is acceptable, 
especially since more results from current DIF-H investments will be achieved in the future, 
and operational efficiency is also good; and 
• Each DIF-H consortium member has performed its specified roles proficiently and as required. 
 
The evaluation’s recommendations focus on refinements going forward. In particular, the need for 
strategic leadership and governance of the consortium, and on continuing improvements in 
performance.  We detail our response to each recommendation, in turn, below. 
 
 
Recommendation 1: Better strategy. DIF-H should develop an applied and dynamic, consortium-level 
strategy for outlining coordination with Canadian aid and other governmental initiatives in global 
health and development. A DIF-H strategy should also formalize expected visibility arrangements and 
improve internal knowledge transfer and cooperation between consortium members. The same is 
recommended of any DIF endeavour into other fields of innovation (e.g., environment, agriculture, 
education, etc.). 
Management Response: Consortium members agree with the recommendation, and note 
some further but important considerations.   
While the Government of Canada did not specifically empower any consortium member, or 
any governance body, to provide strategic leadership for DIF-H per se, the Memorandum of 
Understanding between the consortium members recognizes IDRC’s stewardship role, and the 
Grant Agreement between IDRC and GCC stipulates that IDRC is the steward of DIF-H funds for 
the Government of Canada.   
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Consortium members recognize that the Board of GCC has provided able strategic guidance 
over GCC’s operations and strategy, in that organization’s role as the primary delivery vehicle 
for the Initiative. IDRC’s and CIHR’s governance structures have done the same, where 
necessary, in relation to their respective roles in DIF-H. In the context of the GCC Board, the 
Presidents of both IDRC and CIHR have capably fulfilled their fiduciary responsibilities to GCC.    
Action Plan: While keeping in mind that GCC has served as an alternative service delivery 
mechanism, consortium members recognize that the GCC Board’s strategic guidance and GCC 
strategies are not intended to be substitutes for DIF-H strategies or governance, or integration 
of strategies and activities of each of the consortium members – and this is a matter that the 
Government may wish to consider, particularly going forward, with reference to any other DIF 
endeavours (in health or alternative fields).  
 
Recommendation 2: Strengthen scientific oversight. Although CIHR peer review ensures that funded 
projects are scientifically rigorous at their earliest stages, there are few mechanisms to ensure that 
scientific standards of projects are maintained post-implementation. Mechanisms should be put in 
place to guarantee the scientific integrity of funded projects throughout their life-cycle. While the 
Scientific Advisory Board does review the outcomes of the top performing projects, they are afforded 
insufficient time and data, and they lack sufficient resources and mandate to do this for all projects. 
Therefore a more systematic, but efficient mechanism is needed. GCC’s formation of specialist 
platforms to support the Targeted Challenge and Transition to Scale grand challenges are a step in the 
right direction, but GCC should pay greater attention to the Stars projects. 
The decision that the Scientific Advisory Board should work through sub-committees has resulted in 
reduced scientific leadership and input. Accordingly, opportunities were missed for engagement with 
the strategic direction of GCC and DIF-H (as opposed to the operational work of the individual grand 
challenges). DIF-H must consider these implications and work to ensure that management decisions 
continue to be supported by expert scientific thinking. 
Management Response:  Consortium members agree with this recommendation.  
Action Plan: GCC’s management will develop a plan to strengthen scientific integrity 
throughout the life-cycles of GCC’s projects. This plan will include re-implementation of a full 
Scientific Advisory Board to meet regularly and to play an ultimate scientific advisory role.  The 
plan will also elaborate on how the successes of the specialist platforms will be leveraged going 
forward.  
This plan is expected to be deliberated by GCC’s Board before March 2016. In the meantime, 
GCC management will review and report on existing project management to ensure continued 
scientific integrity. 
 
Recommendation 3: Optimise metrics. The results indicators used by GCC require further refinement to 
make them more precise and objective. Adopting international measures of efficacy which better 
reflect age-weighted health gains would also enable international comparisons of efficiency. The 
evaluators appreciate that there are advantages and limitations of different measurement 
methodologies, but the use of common metrics and benchmarks could help facilitate reporting, and 
form the basis for target setting.  
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Management Response:  Consortium members agree with this recommendation.  
Action Plan: In regular monitoring discussions pursuant to their Grant Agreement, IDRC has 
requested GCC management to review and report on comparators indicators and metrics to 
ensure that, to the extent possible, GCC results can be benchmarked internationally. This 
review should be complete no later than March 2016 and should be shared with the full GCC 
Scientific Advisory Board and, with their inputs and review recommendations, deliberated by 
GCC’s Board by no later than June 2016.  
 
Recommendation 4: More rigorous monitoring and reporting. GCC should undertake a comprehensive 
review of its monitoring and reporting arrangements. These need to be more systematic, transparent 
and consistent, so as to balance the externally facing promotional approach with the need for scientific 
rigor. To ensure credibility, there should be an audit trail connecting raw data to final results claims. 
Management Response: Consortium members agree with this recommendation.  
Action Plan: In regular monitoring discussions pursuant to their Grant Agreement, IDRC has 
requested GCC management to undertake this review, with urgency, with a view to 
standardizing a single project monitoring and reporting database that underpins all GCC 
reporting, while removing any other parallel databases by March 2016. CIHR and IDRC have 
also recommended that GCC consider commissioning, following the present funding phase for 
DIF-H, an independent evaluation of reported results, something not possible under the tight 
timeframes of this summative assessment. 
 
Recommendation 5: Seize efficiency opportunities. GCC is an efficient organization. However, further 
operational investment would increase efficiency to a greater extent and avoid the risk of under-
performance. Although this represents a trade-off with cost minimization, investment in areas such as 
more comprehensive monitoring and additional specialist staff could improve results and reporting that 
will balance the allocative efficiency ratio of inputs to outcomes. In simpler terms, doing more with 
more. 
DIF-H should review the funds allocated to IDRC and CIHR to ensure that they cover the actual costs 
incurred in providing services to DIF-H. This allocation should be based on an estimation of previous 
resource use. Future resources provided to DIF-H should be tracked to prevent under- or over-
allocations.  
Management Response:  Consortium members agree with this recommendation.  
Action Plan: In tandem with GCC reviews of benchmarking and of monitoring and reporting, 
IDRC has requested GCC management to develop a human resources plan to address these 
efficiencies.  This would be presented to the GCC Board for deliberation by June 2016. IDRC has 
also requested CIHR to provide an estimate of actual costs incurred in providing scientific 
reviews of GCC calls, while IDRC will provide an estimate of the costs of IDRC participation in 
the consortium; such estimates to be developed by March 2016 as inputs to any Government 
of Canada decision making around strategic directions of DIF-H and DIF endeavours more 
broadly.  
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management xi 
Table of contents  
Acknowledgments ........................................................................................................................ i 
Executive summary ..................................................................................................................... ii 
Purpose of the evaluation ...................................................................................................... ii 
The Development Innovation Fund – Health ......................................................................... ii 
Methodology ......................................................................................................................... ii 
Findings ............................................................................................................................... iii 
Conclusions and recommendations ....................................................................................... v 
Management response and action plan ................................................................................... viii 
Table of contents ....................................................................................................................... xi 
List of figures ........................................................................................................................... xiii 
List of tables ............................................................................................................................. xiv 
List of abbreviations .................................................................................................................. xv 
Evaluation objectives .................................................................................................................. 1 
Evaluation management ............................................................................................................. 1 
DIF-H program profile ................................................................................................................. 2 
Rationale for Development Innovation Fund – Health ........................................................... 2 
DIF-H objectives .................................................................................................................... 2 
The DIF-H consortium ........................................................................................................... 3 
DIF-H activities ...................................................................................................................... 5 
Methods ...................................................................................................................................... 7 
Structure of the evaluation .................................................................................................... 7 
Methodological approach ...................................................................................................... 7 
Data collection....................................................................................................................... 8 
Analysis............................................................................................................................... 10 
Reporting ............................................................................................................................ 10 
Limitations of the evaluation ................................................................................................ 10 
Findings .................................................................................................................................... 12 
1 Core Issue 1: Continued need for the program .............................................................. 12 
1.1 Does DIF-H address a demonstrable need, and has it evolved to meet emergent 
needs?..................................................................................................................... 12 
1.2 DIF-H responsiveness to the needs of Canadians ................................................... 14 
2 Core Issue 2: Alignment with government priorities ....................................................... 15 
2.1 Alignment with Canadian priorities in international development .............................. 15 
2.2 Alignment with innovation and engagement of the private sector ............................. 15 
2.3 Alignment with Canadian geographical priorities ...................................................... 16 
3 Core Issue 3: Alignment with federal roles and responsibilities ...................................... 17 
3.1 DIF-H support to federal roles and responsibilities ................................................... 17 
3.2 DIF-H alignment and complementarity with Canadian ODA ..................................... 17 
3.3 DIF-H alternative delivery models ............................................................................ 18 
4 Core Issue 4: Achievement of expected outcomes ........................................................ 19 
4.1 Ultimate outcomes ................................................................................................... 19 
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management xii 
4.2 Intermediate outcomes ............................................................................................ 22 
4.3 Immediate outcomes ............................................................................................... 24 
4.4 Outputs produced .................................................................................................... 27 
4.5 Monitoring and reporting of results ........................................................................... 29 
4.6 Results discussion 1: Questioning the DIF-H theory of change ................................ 31 
4.7 Results discussion 2: The importance of considering future results ......................... 36 
5 Core Issue 5: Demonstration of efficiency and economy ............................................... 37 
5.1 Economy ................................................................................................................. 37 
5.2 Efficiency ................................................................................................................. 38 
5.3 Allocative efficiency ................................................................................................. 39 
5.4 Operational efficiency .............................................................................................. 41 
5.5 Structure, governance and processes of DIF-H ....................................................... 43 
Conclusions and recommendations .......................................................................................... 49 
Relevance ........................................................................................................................... 49 
Performance ....................................................................................................................... 49 
Future considerations .......................................................................................................... 51 
Recommendations .............................................................................................................. 52 
References ............................................................................................................................... 54 
Annexes .................................................................................................................................... 57 
A. Evaluation management plan .......................................................................................... 57 
B. Evaluation matrix ............................................................................................................ 61 
C. Information on data sources used to inform this evaluation ............................................. 70 
D. Case study 1: Rapid syphilis tests as a catalyst for health system strengthening: a case 
study from Peru ....................................................................................................... 75 
E. Case study 2: Saving Brains, Leonid Lecca, HPI and Socios en Salud: The Casitas 
project...................................................................................................................... 77 
F. GCC Logic model used to measure achievement of expected results ............................. 78 
 
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management xiii 
List of figures 
Figure 1: The DIF-H theory of change ............................................................................................. 4 
Figure 2: Conceptual diagram of the DIF-H consortium and its responsibilities ............................... 5 
Figure 3: A conceptual representation of sampling for data triangulation ........................................ 8 
Figure 4: Summary of data collection exercises and the evidence they contribute to each core issue
 ............................................................................................................................................ 9 
Figure 5: Proportion of DIF-H funds allocated by region ................................................................ 25 
Figure 6: Graphical representation of the geographical distribution of respondents ....................... 74 
  
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management xiv 
List of tables 
Table 1: Requests for proposals and application statistics for each grand challenge ...................... 5 
Table 2: DIF-H budget allotment by consortium member ................................................................ 6 
Table 3: DIF-H financial outlays by GCC (to date) ........................................................................... 6 
Table 4: Number of lives saved claimed for each GCC data source .............................................. 20 
Table 5: Number of lives improved claimed for each GCC data source ......................................... 21 
Table 6: Number of target beneficiaries who accessed an innovative health product or service, for 
each data source ............................................................................................................... 23 
Table 7: Breakdown of project funds leveraged ............................................................................ 29 
Table 8: Influence of respondents’ primary institution location on project outcomes ...................... 32 
Table 9: Proportion of GCC’s operational costs compared to grants given .................................... 41 
Table 10: Operational costs of DIF-H in C$ ................................................................................... 42 
Table 11: Results sources by type of report, date when current, and number of projects in portfolio 
at this time. ........................................................................................................................ 72 
Table 12: Results sources by type of report, date when current, and number of projects that results 






Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management xv 
List of abbreviations 
 
C$   Canadian dollar 
CIHR  Canadian Institutes of Health Research 
DALY  Disability-adjusted life years  
Diagnostics  Point-of-Care Diagnostics – Grand Challenge 
DIF-H  Development Innovation Fund – Health 
DFATD  Department of Foreign Affairs, Trade and Development  
DFID  Department for International Development (United Kingdom) 
Explorations  Grand Challenges Explorations – Grand Challenge 
GCC  Grand Challenges Canada 
HIC  High-income country 
IDRC  International Development Research Centre 
LMEF  Learning Monitoring and Evaluation Framework 
LMIC  Low-and middle-income country 
ODA  Official development assistance 
OECD-DAC  Organisation for Economic Co-operation and Development – Development 
Assistance Committee  
OPM  Oxford Policy Management 
QALY  Quality-adjusted life years  
SLAB  Saving Lives at Birth – Grand Challenge 
Stars  Stars in Global Health – Grand Challenge 
TTS    Transition to Scale – Grand Challenge 
USAID   United States Agency for International Development  
WHO   World Health Organization 
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management   1 
Evaluation objectives  
Building on the formative evaluation conducted in 2011, this reports presents a summative 
evaluation of the Development Innovation Fund – Health (DIF-H). Covering the period 2008 
to 2015, this evaluation determines the extent to which DIF-H is a relevant investment for the 
Government of Canada, and whether it has met its objectives.  
The primary user of this evaluation is the Government of Canada, as the principal funder of 
DIF-H. The evaluation will be used as part of the Government of Canada’s commitment to 
accountability for results and assessing program effectiveness. Secondary users of the 
evaluation are Grand Challenges Canada (GCC), the International Development Research 
Centre (IDRC), and the Canadian Institutes of Health Research (CIHR), as the members of 
the DIF-H consortium. These organizations will use evidence derived from the evaluation to 
make organization level decisions about DIF-H programming. Tertiary users of the evaluation 
include the global health research community, the innovation community, and Canadians at 
large. All of these parties may hold interest in evaluation results for reasons of furthering a 
shared understanding of innovative research funding approaches or for accountability 
reasons.
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Evaluation management 
Responsibility for the management of the evaluation of the DIF-H was directed to the IDRC 
by the Treasury Board Secretariat of Canada (TBS) through Memorandum to Cabinet. The 
evaluation that follows upholds the highest principles of quality and independence. For 
further detail, Annex A comprehensively outlines the evaluation management procedure.  
 
Under the management of IDRC, an external and independent evaluator was commissioned 
to conduct this evaluation. A team from Oxford Policy Management — an Oxford, England, 
based consulting firm — was selected through a competitive process, based on 
requirements of expertise, knowledge, and experience that were set and agreed upon by the 
DIF-H consortium.  
 
An oversight structure was developed to assist the IDRC Evaluation Office in its evaluation 
management role. This oversight structure ensured a transparent and collaborative, yet 
independent, process of review. The structure comprised two discrete committees:     
 
1. The DIF-H Evaluation Committee was charged with thorough discussion of issues 
pertinent to the evaluation. It was convened by the Evaluation Office of the IDRC and 
was composed of senior level representatives of each consortium member — IDRC, 
GCC, and CIHR.   
2. The DIF-H External Oversight Committee was charged with approval of three 
issues: 1) selection of the evaluator; 2) evaluation design; and 3) the final evaluation 
report. The committee was convened by the Evaluation Office of the IDRC, and 
chaired by the head of Evaluation at IDRC (as a non-voting member). The Committee 
comprised three external subject area experts who are fully independent of each 
consortium member:   
• François Dumaine, LLL, MA, CE — Partner at PRA Inc.; Past President of the 
Canadian Evaluation Society; 
• Kathryn Graham, Ph.D. — Executive Director Performance Management and 
Evaluation, Alberta Innovates – Health Solutions; 
• Kathryn Wehr, MPH — Program Officer, Robert Wood Johnson Foundation. 
Upon completion, this report was externally peer-reviewed for quality assurance by Dr. 
Charles Lusthaus, co-founder of the international development and evaluation consulting firm 
Universalia, and retired professor at McGill University, Montréal.   
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DIF-H program profile 
Rationale for Development Innovation Fund – Health  
In 2008, the Government of Canada established the Development Innovation Fund – Health 
(DIF-H), pledging $225 million over five years to support breakthrough research that 
addresses critical global health problems to bring lasting improvements to the health and 
lives of people in low-income countries (Government of Canada, 2008).1 
DIF-H is managed by a consortium of three organizations: the International Development 
Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR), and Grand 
Challenges Canada (GCC). Their roles and responsibilities are presented below.  
On May 3, 2010, the Honourable Jim Flaherty announced the launch of Grand Challenges 
Canada. GCC was launched in 2010 and has developed programs for researchers from 
Canada and low- and middle-income countries (LMICs) targeted in different areas, including 
Point-of‐Care Diagnostics, Women’s and Children’s Health, Global Mental Health, and 
Hypertension. In addition, the Stars in Global Health program supports research on 
“innovator‐defined” global health challenges. Many of these programs have been undertaken 
in partnership with other institutions, in addition to CIHR and IDRC, including the Bill and 
Melinda Gates Foundation, the United States Agency for International Development, and the 
United Kingdom’s Department for International Development, among others. 
DIF-H is therefore a fund, a consortium, and a delivery mechanism.  
As described in the terms of reference (IDRC, 2015) the purpose of this summative 
evaluation is to “…determine the extent to which DIF-H is succeeding. However since the 
ultimate results for DIF-H are not expected within the summative evaluation timeline, the 
evaluation will need to determine what has been accomplished to date in terms of results 
and what can be said about the likelihood of future expected results.”  
DIF-H objectives  
The Government of Canada indicated that the Development Innovation Fund could 
eventually become a multi-sectoral support fund, but that the initial focus was to be on global 
health. It was therefore named the Development Innovation Fund – Health.  
DIF-H’s mission is threefold (IDRC, 2015): 
1. Identify and prioritize profound health challenges facing the developing world. 
2. Mobilize scientific communities in Canada and the rest of the world, including in the 
developing world, to address these health challenges through competitive selection 
and funding of projects.  
3. Facilitate the affordable implementation and commercialization, in developing regions 
of the world, of solutions that emerge. 
                                               
1 This budget plan was tabled in the House of Commons by the Honourable Jim M. Flaherty, P.C., M.P., Minister 
of Finance. 
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The logic for DIF-H and the expected pathways to achieving these objectives are presented 
in the DIF-H theory of change (Sridharan et al., 2011) (see Figure 1).  
The DIF-H consortium  
The DIF-H was designed as a consortium of three organizations, namely, the International 
Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR), 
and Grand Challenges Canada (GCC). Each organization’s specific roles and responsibilities 
were established by the Treasury Board decision that initiated DIF-H. A memorandum of 
understanding between IDRC, CIHR, and GCC specified the funding relationship between 
the three organizations.  
 
IDRC is responsible to the Government of Canada for the ultimate oversight of the DIF-H. 
IDRC delivers its DIF-H-related responsibilities through: 1) the operational support it provides 
to GCC, mainly relating to institutional set-up; 2) ensuring the accountability of DIF-H to the 
government; and 3) managing the formative and summative evaluations and audits of DIF-H.  
 
CIHR is responsible for peer-reviewing applications in response to GCC grant calls, which 
are funded by DIF-H. The DIF-H grant award system is administrated by CIHR in accordance 
with international standards of excellence.  
 
GCC is a purpose-built not-for-profit organization created to be the DIF-H implementation 
arm. Therefore, while IDRC is responsible for oversight of DIF-H, GCC is responsible for the 
projects that are funded by DIF-H and, therefore, the delivery of the identified policy priorities 
and the monitoring and evaluation of funded projects. GCC delivers its DIF-H mandate by 
funding innovators in the field of global health, with a focus on innovators from LMICs. 
Grants and zero interest loans are awarded through a challenge fund mechanism that 
currently has three main windows:  
 
1. Targeted challenges that fund innovators to work on specific global health issues. The 
targeted challenges are maternal, newborn, and child health (Saving Lives at Birth — 
SLAB) implemented in collaboration with key partners such as the United States Agency 
for International Development (USAID), early childhood development (Saving Brains), 
and mental health (Global Mental Health). During the first two years of GCC’s existence 
(2009–2010) there were also targeted challenges focused on Point-of-Care Diagnostics 
(Diagnostics) and Hypertension.  
 
2. Challenges to fund innovators in global health with no pre-identified theme. This 
program, initially called Rising Stars, is now known as Stars in Global Health (Stars).  
 
3. Challenges to enable promising innovations to transition to scale (GCC, no date).2 
This has been known as Bridge Funding, Direct Entry, and Transition to Scale and is 
now called Transition to Scale (TTS). Transition to Scale spans across the targeted 
challenges and Stars in Global Health programs. 
 
A conceptual diagram of the DIF-H consortium and its responsibilities is presented in Figure 
2 below.
                                               
2 Provided by GCC as part of the material for the summative evaluation. 
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Figure 1: The DIF-H theory of change 
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Table 1 summarizes the number of requests for proposals implemented and application 
statistics for each grand challenge. Table 2 shows the allotment of DIF-H budget by 
consortium member. Table 3 outlines DIF-H financial outlays by GCC.   
 
Table 1: Requests for proposals and application statistics for each grand challenge 














5 4 3 1 
Total no. of 
applications received  
2,692 63 342 2,101 206 205 
Total no. of 
applications selected 
480 41 48 65 42 12 
% success rate  
 
18% 65% 14% 3% 20% 6% 
Source: Grand Challenges Canada (2015). Application Statistics. April 2015 
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Table 2: DIF-H budget allotment by consortium member 
 
Source: IDRC data  
 
Table 3: DIF-H financial outlays by GCC (to date) 
 Grand challenge program 
No. of 
projects 













Stars - Proof-of-Concept 471 50,840,661 50,432,726 23,269,743  
Transition to Scale 31 13,740,069 6,107,666 36,162,151  
Grand Challenges 
Explorations 
6 2,460,781 2,413,147 3,390,842  
Point-of-Care Diagnostics 12 12,518,255 11,414,715 16,962,155 36,798,033 
Total 520 79,559,766 70,368,254 79,784,891 36,798,033 
Targeted grand 
challenges 
Saving Lives at Birth 25 7,739,390 6,180,940 1,489,165 42,819,858 
Saving Brains 52 31,309,929 24,023,184 5,761,130 900,000 
Global Mental Health 51 28,232,030 21,590,321 1,297,946 - 
Hypertension — Global 
Alliance for Chronic Diseases 
6 2,277,835 1,073,288 - 4,006,638 
Total 134 69,559,184 52,867,733 8,548,241 47,726,496 
Testing new 





Impact Investment Funds 
(Global Health Investment 
Fund) 
1 9,781,827 9,781,827 - 96,368,300 
Innovative Development 
Financing 
- - - - - 
Total 1 9,781,827 9,781,827 - 96,368,300 
Research support 
activities 
Total — Research Support 
Activities 
- 6,111,913 6,111,913 - - 
Source: GCC figures: Strategy Roadmap, March 2015; IDRC and CIHR figures: DIF-H budget allocation, 2008
Consortium member Allotment of DIF-H budget 
IDRC 4,500,000 
CIHR  900,000  
GCC 165,012,690 
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Methods 
The methodology for the summative evaluation of DIF-H was comprehensively presented in 
the evaluation design report developed in March 2015. Prior to being implemented, the 
evaluation design was reviewed and approved by all DIF-H consortium members, and by the 
evaluation’s External Oversight Committee. 
Structure of the evaluation 
In keeping with the requirements of the Treasury Board, this evaluation was structured by 
reference to the core issues for evaluations of federal programs presented in the Policy on 
Evaluation (TBS, 2009). These core issues assess the value for money of federal 
investments. This refers to the extent to which programs demonstrate relevance and 
performance.  
Relevance is demonstrated by the extent to which a program responds to Core Issues 1, 2, 
and 3, namely: 
1. Continued need for the program: Assessment of the extent to which the program 
continues to address a demonstrable need and is responsive to the needs of 
Canadians; 
2. Alignment with government priorities: Assessment of the linkages among program 
objectives and federal government priorities; 
3. Alignment with federal roles and responsibilities: Assessment of the role and 
responsibilities of the federal government in delivering the program. 
Performance is demonstrated by the extent to which the program responds to Core Issues 4 
and 5, namely: 
4. Achievement of expected outcomes: Assessment of progress toward expected 
outcomes (including immediate, intermediate, and ultimate outcomes); 
5. Demonstration of efficiency and economy: Assessment of resource utilization in 
relation to the production of outputs and progress toward expected outcomes.  
To achieve a rigorous evaluation according to these criteria, the evaluators developed a 
comprehensive evaluation matrix based on these core issues. The evaluation matrix 
presents the key evaluation questions for each core issue and the indicators that were used 
to assess DIF-H, as well as the data sources and methods that were used to collect 
evidence on the indicators. This evaluation matrix is presented in Annex B. 
Methodological approach 
The selected methodology was inspired by contribution analysis. This theory-based 
evaluation methodology can enable robust conclusions and credible assessments of cause 
and effect, even for complex interventions. Furthermore, this method supports the in-depth 
assessment of outcomes by explicitly incorporating the DIF-H theory of change into the 
evaluation. Our approach to contribution analysis was guided by the methodology set out by 
John Mayne (Mayne, 2008; 2009). The methodology was approved by the External 
Oversight Committee.  
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Data collection 
Mixed methods were used to triangulate and cross-check findings between DIF-H reports 
and independently collected primary data. A conceptual diagram demonstrating triangulation 
is shown in Figure 3. 
Figure 3: A conceptual representation of sampling for data triangulation 
 
Source: Adapted from Toulemonde and Delahais (2014) 
Secondary data on DIF-H inputs, activities, outcomes, and their relevance were captured by 
reviewing program documents and wider white and grey literature. Aggregated results claims 
in GCC documents were then validated by cross-checking them against a disaggregated 
project database.  
Independently collected primary data were captured by conducting interviews and focus 
groups with DIF-H staff, stakeholders, and external experts. To assess if the findings from 
interviews and focus groups were representative of the experience of grantees implementing 
projects, field-based case studies were conducted in Peru. These consisted of interviews 
and focus groups with grantees and local stakeholders, and observations of project activities.  
To determine if the findings presented in the case studies and DIF-H documents were 
representative of DIF-H beneficiaries’ experiences, an online survey was administered to 
DIF-H applicants and grantees.  
A summary of the data collection exercises and the evidence they contributed to each core 
issue is presented in Figure 4. The full list of data sources used in this evaluation are 
described in Annex C, and the resultant data they contributed to the evaluation are 
summarized in the evaluation matrix (Annex B). Summaries of the two project case studies in 
Peru are presented in Annex D and E. Names and details of respondents are not provided in 
order to protect confidentiality and anonymity. 
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Figure 4: Summary of data collection exercises and the evidence they contribute to 
each core issue 
 
Report of the Expert Review Panel on Grand Challenges Canada 
In addition to the evaluation activities undertaken by the evaluation team, the board of 
directors of Grand Challenges Canada commissioned separately an international Expert 
Review Panel to review GCC’s impact and outcomes over its first five years of operations, 
and to provide recommendations for its future direction.  
According to the draft report of the Expert Review Panel on GCC, “the panel met several 
times via teleconference and at an in-person retreat in Toronto, Ontario, in July 2015. 
Members were briefed by management and staff from Grand Challenges Canada about its 
programs and activities, reviewed a number of documents and reports, and conducted a 
number of in-person and group interviews with Grand Challenges Canada’s innovators and 
other stakeholders” (Morin, 2015). 
The summative evaluation of DIF-H contained in this report was an independent process 
from that conducted by the Expert Review Panel. However, it was requested that the 
evaluation team have some interaction with the Expert Review Panel and consider its 
findings as another data source, where appropriate. To this end, the evaluation team leader 
spoke with Marie-Lucie Morin, the chair of the Expert Review Panel, and the evaluators were 
provided with a preliminary draft report of the Expert Review Panel’s findings.  
The evaluators note that the Expert Review Panel has brought a great deal of expertise to 
bear and produced a well-considered report, particularly regarding international thinking on 
the relevance of GCC. However, it should be understood that the Expert Panel Review was a 
discrete process from the summative evaluation and therefore the evaluators cannot 
comment on its validity, nor endorse it.  
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Analysis 
Data were analyzed using a framework analysis approach (NatCen Learning, 2012). This 
involved summarizing and condensing the most important information that arose from the 
data collection activities, and inserting the summaries into a framework that linked the 
evidence, and the source it came from, to each question in the evaluation matrix. This 
evidence was then regularly reviewed to assess if it was sufficiently comprehensive to draw 
robust conclusions.  
Reporting 
Emerging evaluation findings were presented to the DIF-H consortium senior management 
during an in-person meeting in Ottawa. DIF-H consortium members then commented on 
these findings, which were incorporated into a draft final evaluation report. This draft report 
was reviewed by each consortium member, followed by an external review organized by 
IDRC, and was subsequently approved by the External Oversight Committee. This final draft 
reflects the conclusive views of the independent evaluator, Oxford Policy Management.   
Limitations of the evaluation  
GCC provided a number of documents that present aggregated claims for the results 
achieved by the DIF-H-funded projects. It is important to understand that these results claims 
are based on reports made by project grantees submitted to GCC through routine monitoring 
procedures. GCC project officers review and critique these claims to check that they are 
plausible, and seek further information from grantees, if required. The results may then be 
adjusted based on these discussions.  
Limitation 1: Although this monitoring approach is not uncommon, it does mean that data 
are self-reported, and in the absence of systematic audits of project results, there is no way 
to confirm their validity.   
Mitigation strategy: In an attempt to understand and confirm the aggregated results claims 
made in the results documents, the evaluators independently analyzed the results of 
individual projects presented in the GCC project database. However, when reporting results, 
GCC explicitly focuses on its top performing projects, highest investments, and projects that 
have been completed. Furthermore, there are several results documents that represent 
results from different points in time, so the more recent data sources include more projects 
as these projects begin to generate results or are completed. GCC has also been refining its 
approach to calculating results and therefore may update results claims previously presented 
in data sources. Tables 12 and 13 in Annex C show the data sources, when these sources 
were current, the total number of projects that were in the portfolio at that time, and the 
number of projects that their results claims are based upon. 
Limitation 2: The outcome of this reporting approach is that there are multiple results 
claims, and there is missing information for projects that are not considered top performing or 
are incomplete. Therefore the independent analysis of the GCC database was not able to 
pinpoint an exact figure of the results achieved by DIF-H.  
Limitation 3: Due to missing project outcome information, the project database validation 
will under-report results compared to GCC results claims documents. Furthermore, the 
bases for some claims are unknown because they could not be cross-checked.  
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Mitigation strategy: To capture more comprehensive data on individual projects and cross-
reference the GCC-reported claims with an independent source, the evaluators conducted a 
survey of GCC applicants and grantees. However, it is important to note that the survey 
results for the grantees may be subject to positive reporting bias. This bias arises when 
individuals requested to take part in a survey are more likely to respond if they have positive 
results to report. Because approximately 50% of grantees responded to the survey, it is 
possible that the survey collected disproportionately more responses from “successful” 
grantees. Furthermore, when interpreting the results, it is also important to note that the 
validity of the grantee-reported claims was not cross-checked. Therefore, it is possible that 
grantees could under- or over-report results. If this response bias occurred, it would normally 
result in higher claims of success than actually occurred (Furnham, 1986).  
Limitation 4: While the survey provides an alternative data source to determine the results 
achieved by DIF-H, it cannot be considered objective and has its own reliability limitations. 
Importantly, there is potential for biases that could inflate the reported results achieved.   
Mitigation strategy: All the above data are based on grantee self-reports. The qualitative 
interviews and focus group discussions provide an alternative source of information with 
which to cross-check the self-reported results. The field visit in Peru was particularly helpful 
because it allowed the evaluation team to meet with and observe DIF-H-funded projects and 
grantees and consider if the evaluation findings appear representative of what is actually 
happening on the ground. However, resource constraints meant that case studies could only 
be conducted in one country and it is still possible that key informant responses were biased. 
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Findings 
 
1 Core Issue 1: Continued need for the program 
1.1 Does DIF-H address a demonstrable need, and has it evolved to 
meet emergent needs? 
Main message: DIF-H addresses demonstrable needs for Canadians and the international 
community. 
• Needs addressed by DIF-H include the continuing need for financing to support 
innovations in global health, resolving barriers to global health and safety, and promoting 
development and equity in low- and middle-income countries (LMICs). 
• Innovation is recognized as a relevant and cost-effective way to address global health 
challenges in LMICs. 
• Investment in DIF-H has contributed to positioning Canada at the forefront of 
international efforts to rethink development modalities. 
• DIF-H provides Canadian innovators with increased opportunities to engage with LMIC 
innovators and research institutions.  
• The Canadian public values this national support to international development and global 
health, as it recognizes the potential dangers of global health risks. 
1.1.1 Global health as an international development priority 
Global health continues to be a priority in international development. The Sustainable 
Development Goals (SDGs) recognize that progress has been made in some areas, but new 
approaches and greater resources and effort are required to resolve persistent barriers to 
global health and equity (United Nations, 2015b; World Health Organization [WHO], 2013b). 
The DIF-H-funded targeted grand challenges and many of the innovator-defined projects are 
particularly aligned with the following SDGs (United Nations, 2015a): 
• Goal 2: End hunger, achieve food security and improved nutrition and promote 
sustainable agriculture 
• Goal 3: Ensure healthy lives and promote well-being for all at all ages 
• Goal 6: Ensure availability and sustainable management of water and sanitation for all 
• Goal 9: Build resilient infrastructure, promote inclusive and sustainable 
industrialization, and foster innovation 
• Goal 17: Strengthen the means of implementation and revitalise the global partnership 
for sustainable development 
There is also some alignment with Goal 5: achieve gender equality and empower all women 
and girls. 
Canadians increasingly recognize that improvements in global health contribute to increased 
global safety by addressing risks from pandemics and new/emerging diseases that 
transcend geographic boundaries and may be very difficult to manage once they are 
established. These challenges require both a continued investment in health systems 
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strengthening and an intensified search for targeted, innovative solutions (WHO, 2013b). The 
relationship between population health and economic development is also well established 
and represents an important additional rationale for investment in DIF-H (WHO Commission 
on Macroeconomics and Health, 2001; Lancet Commission on Investing in Health, 2013). 
Owing to their different remit, the findings of the Expert Review Panel on GCC provide more 
detailed discussion on the alignment of GCC grand challenges with international health 
priorities. In general, there is agreement between the findings of the Expert Review Panel 
and this summative evaluation of DIF-H on this issue.  
1.1.2 The relevance of innovation to global health development 
There is a growing recognition of the need to continue with and increase investments in 
innovations for global health; funding of projects through DIF-H directly responds to this 
need. Evaluation of the precursor to the SDGs, the Millennium Development Goals, shows 
that a significant proportion of the gains in MDGs 4, 5, and 6 were related to research and 
development investments (WHO, 2013b). A number of international fora, including the Global 
Health and Innovation Conference held at Yale University in March 20153 and the United 
Nations Strategy “Every woman every child,”4 have articulated this need.  
The literature also suggests that the global community is facing an “implementation 
bottleneck.” Weak infrastructure and health systems result in an inability to deliver 
innovations and other effective interventions at scale (Whitworth et al., 2010). Given this 
situation, there is a push for more research and innovation to create new technologies, and 
to turn existing knowledge into practical applications (WHO, 2013b).  
The Lancet Commission on Investing in Health (2013), “Global Health 2035 – a World 
Converging within a Generation,” suggests that research and development for new 
technology and scaling can save lives and can be highly cost-effective (Lancet Commission 
on Investing Health, 2013). The World Health Report 2013 also highlighted the importance of 
supporting local ideas and targeting more research attention to specific LMICs’ global health 
issues, and noted that the yield from such investments is potentially very high where 
coverage of large beneficiary populations is achieved (Lancet Commission on Investing in 
Health, 2013). 
1.1.3 New approaches to global health development  
There is a growing opinion that the current modalities of development should be challenged 
and a new ecosystem for development created.5 For example, USAID launched a broad 
reform in 2010, with seven main priorities, including technology and innovation. Investment in 
DIF-H increases Canada’s influence in these international discussions, which include new 
approaches to aid delivery, more systematic inclusion of beneficiaries as active participants, 
stronger engagement by the private sector, robust measurement of impacts, and high-quality 
evaluation.   
In the Canadian context, there is a move toward greater partnership in ODA with the private-
for-profit and private-not-for-profit sectors, and that has provided a greater emphasis on 
innovation. Pierre Jacquet, President of the Global Development Network, recently made the 
                                               
3 See www.uniteforsight.org/conference/ 
4 See https://sustainabledevelopment.un.org/sdinaction/everywomaneverychild 
5 An ecosystem for development is defined by Runde and Savoy (2004) as “a conglomeration of various entities 
to deliver aid, including non-profit and for-profit organizations, governments, multilateral institutions, NGOs and 
foundations.” 
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case for the utilization of ODA to create mechanisms for risk-sharing between the private and 
the public sector, under the supposition that this will attract private investment to 
development activities and support development-focused entrepreneurship (Mirabile and 
Schmerler, 2014).6  
It is the opinion of several external key informants, the Expert Panel, and the evaluators that 
the DIF-H fund has helped to position Canada as an influential participant in these 
international efforts to rethink modalities for global health and development. 
1.2 DIF-H responsiveness to the needs of Canadians 
DIF-H provides increased opportunities for Canadian innovators and institutions to work with 
counterparts in LMICs. The universities of Toronto, British Columbia, Calgary, and Alberta, 
and McGill University are among the institutions that have single and or multi-country LMIC 
partners. The funding provided by DIF-H represents an important addition to the global 
health and innovation opportunities available to Canadian researchers and innovators. GCC 
also provides individual and institutional capacity development activities through training and 
networking that mutually benefit Canadian and LMIC researchers.  
DIF-H also has relevance in relation to the needs of the Canadian government, policy-
makers, and the public. Canadians are increasingly aware that they are not isolated from the 
health problems that affect the lives of people around the world, as was recently 
demonstrated by the H1N1 outbreak (Blendon et al., 2004; Public Health Agency of Canada, 
2010). Indeed, the Canadian government estimates that Canadians have contributed $110 
million7 to combating the recent Ebola outbreak. The projects funded by DIF-H could provide 
important tools for contributing to the fight against global health threats, and thereby protect 
Canadian interests.  
Canadians also consider the kind of work undertaken by DIF-H to be valuable. A recent poll 
by Angus Reid8 found that “77% of Canadians think that it is important for Canada to be 
known as a world leader in funding solutions to reduce poverty and advance child and 
maternal health initiatives” (Make Poverty History Canada, 2010). The poll concluded that 
“Canadians are a compassionate and generous people. [They] are proud of [their] 
commitment to help the poorest and most vulnerable at home and abroad. Canadians expect 
their government to lead by example in the area of international assistance by delivering on 
its promises; ensuring aid is effective and implementing innovative approaches to 
development cooperation” (Department of Foreign Affairs, Trade and Development Canada, 
2013).
                                               
6 President of the Global Development Network, in an OECD book, 2014. 
7 See www.healthycanadians.gc.ca/diseases-conditions-maladies-affections/diseases-maladie/ebola/response-
response/index-eng.php?id=response  
8 In June 2010, before the G8 Summit in Toronto, Canadians were polled by Angus Reid, in partnership with 
Make Poverty History.ca. 
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2 Core Issue 2: Alignment with government priorities 
Main message: DIF-H is well aligned with the Government of Canada’s thematic priorities 
in global health, development, and innovation.  
• Global health is a priority for Canadian official development assistance (ODA). Within 
global health, maternal, neonatal, and child health is a key priority.  
• Innovation is considered to be a key development modality by the government, 
nationally and internationally.  
• There is partial geographical alignment with countries of focus for Canadian ODA.  
 
2.1 Alignment with Canadian priorities in international 
development 
 
The Official Development Assistance Accountability Act (Ministry of Justice, 2013) states that 
Canada’s ODA is to be “provided with a central focus on poverty reduction and in a manner 
that is consistent with Canadian values, Canadian foreign policy, the principles of the Paris 
Declaration on Aid Effectiveness of March 2, 2005, sustainable development and democracy 
promotion and that promotes international human rights standards.” In terms of sectoral 
priorities, Canada has identified six priorities: 1) increasing food security; 2) securing the 
future of children and youth; 3) stimulating sustainable economic growth; 4) maternal, 
newborn, and child health; 5) advancing democracy; and 6) promoting stability and security.  
In 2010 the Prime Minister of Canada declared that maternal, newborn, and child health 
remains the government’s number one development priority. Canadian contributions to 
maternal, newborn, and child health have been delivered through the finance and leadership 
of the Muskoka Initiative (2010–2015) and the Global Financing Facility for the global 
movement, “Every Woman, Every Child.” The Canadian Academy of Health Sciences report, 
“Canadians Making a Difference,” suggests that maternal and child health, and 
communicable and non-communicable diseases (including mental health), continue to be 
among the key global health issues.  
The investments that GCC is making through Saving Lives at Birth (SLAB), Saving Brains, 
and Global Mental Health all directly align with these Canadian government priorities. Many 
of the grants made through the Stars in Global Health (Stars) grand challenge also relate to 
these thematic priorities. Evidence from key informants strongly supports the view that DIF-
H’s support to maternal and child health has helped to leverage international attention and 
attract additional sources of finance. Key informant interviews and the Expert Panel Review 
further referenced how GCC has brought attention to neglected areas of global health such 
as global mental health.  
2.2 Alignment with innovation and engagement of the private 
sector 
The federal government’s funding of DIF-H as a vehicle for innovation is highly consistent 
with its roles and responsibilities and policies. In the health sector, Canada promotes 
innovation to ensure a sustainable health care system. It funds institutions such as the 
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Canadian Institute for Health Information and the Canadian Agency for Drugs and 
Technologies in Health, which support the use of innovation for developing technologies to 
address domestic health challenges (Health Canada, no date). Internationally, the federal 
government supports innovation through agencies such as IDRC. In 2009 the board of 
governors of IDRC approved a Strategic Framework (2010–2015), which had science, 
technology, and innovation as one of four areas of focus (IDRC, 2009). Innovation is also a 
theme that runs through two of the Department of Foreign Affairs, Trade and Development’s 
(DFATD) priorities for 2015 to 2016 (DFATD, 2015).  
The Government of Canada is committed to innovation in health and other sectors, working 
in close partnership with both the public and private sectors. In considering its aid profile, the 
Organisation for Economic Co-operation and Development (OECD) Development Assistance 
Committee (DAC) recognizes Canada as a country that “promotes ODA as a catalyst to bring 
private sector investment to support development efforts in partner countries” (OECD, 2014). 
DIF-H is also broadly aligned with other Canadian government sectors, such as industry and 
trade. The Economic Action Plan 2015 announced in the 2015 federal budget will provide 
$1.5 billion in funding over five years to advance the government’s renewed science and 
technology strategy (Government of Canada, 2015). This includes stable long-term support 
for advanced research through the federal granting councils and the Canada Foundation for 
Innovation. DIF-H is consistent with this policy direction of the government, as demonstrated 
by GCC being mentioned in the 2015 budget. 
2.3 Alignment with Canadian geographical priorities 
Canada identifies countries of focus for receipt of its ODA support. Currently there are 25 
priority countries, including a subset of 10 countries (Afghanistan, Bangladesh, Ethiopia, 
Haiti, Malawi, Mali, Mozambique, Nigeria, South Sudan, and Tanzania) where support is 
particularly needed in the area of reproductive, maternal, neonatal, and child health 
(Government of Canada, 2014).  
While DIF-H grants are broadly aligned with these ODA foci, DIF-H supports grantees in 
many more countries (n=54) than there are ODA priority countries. Therefore some DIF-H 
grants are inevitably given to countries that are not ODA priority countries. However, the 
evaluators identified a compelling argument as to why this apparent lack of alignment should 
not be a matter for concern: if and when innovations are scaled up, these innovations are 
expected to benefit ODA priority counties.  
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3 Core Issue 3: Alignment with federal roles and 
responsibilities 
 
Main message: The consortium mechanism for DIF-H was relevant for the management of an 
innovation fund and as a funding delivery vehicle.  
• The decision to create GCC as a new organization is appropriate and remains valid at the 
present time. 
• DIF-H lacks a clear strategic vision for coordinating with, and working alongside, the wider 
governmental aid effort. 
3.1 DIF-H support to federal roles and responsibilities 
The development of innovation requires an approach that is based on rigorous science, yet is able 
to be adaptive and responsive, while also managing the risks that are inherent when investing in 
innovations. The DIF-H consortium was specifically set up to provide these inputs by leveraging 
the strengths of each consortium member: CIHR with its excellence in scientific rigour; GCC as a 
flexible and responsive delivery vehicle; and IDRC providing oversight and accountability through 
its years of experience and reporting line to the government.  
In adopting the consortium approach to program delivery, a decision was taken not to establish a 
governance structure for DIF-H. Rather, DIF-H was created without a board of directors, without a 
leadership structure, and without an overarching, program-wide strategy. Instead, both IDRC and 
CIHR are represented on the GCC board by their respective presidents. From the Government of 
Canada’s point of view, this was an important consideration as it allowed the government’s 
interests to be represented at board discussions and in the development of GCC strategy.  
3.2 DIF-H alignment and complementarity with Canadian ODA9 
DIF-H follows the DFATD Report on Plans and Priorities insofar as it focuses on one of its ongoing 
priorities: “lead Canada’s international efforts to reduce global poverty and provide humanitarian 
assistance” (DFATD, 2014). The report states under this priority: “Canada will continue to show 
global leadership in improving maternal, newborn, and child health, building on the successful 
investments of the Muskoka Initiative on Maternal, Newborn and Child Health. Canada’s 
international development initiatives will remain focused on alleviating poverty by pursuing new and 
innovative partnerships, particularly with the private sector.”10 As mentioned in Section 1.1. DIF-H 
focuses both on maternal, newborn, and child health as well as on pursuing new and innovative 
partnerships. 
In a report to Parliament on the government’s ODA in 2013, Canada’s Minister of International 
Development, declared that a whole-of-government approach was required to respond to Canada’s 
international assistance priorities. This should involve the various federal departments and 
agencies working together to provide ODA according to their respective mandates and 
competencies (DFATD, 2013). In this line, DIF-H offers a valuable contribution to Canada’s 
                                               
9 ODA is defined as flows of official financing administered with the promotion of the economic development and welfare 
of developing countries as the main objective, and which are concessional in character, with a grant element of at least 
25%. Source: OECD Glossary of statistical terms: Official Development Assistance (ODA). 
10 Ibid.  
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diplomatic agenda by providing an important entry point for engagement with LMIC countries. GCC 
has also established an impressive set of both formal and informal international partnerships, 
networking groups, and opportunities, which allow countries, organizations, and grantees to share 
ideas and promote innovation for health. 
However, at a more strategic level there remain opportunities to better coordinate the GCC-funded 
activities with the general thrust (as opposed to program-to-program linkages) of other government 
development programs. DFATD’s health systems strengthening strategies and IDRC and CIHR’s 
knowledge translation strategies could serve to strengthen the implementation of innovations 
arising from GCC’s activities. As GCC’s operations and influence grow, it should consider a joint 
exercise with relevant agencies to develop a strategy for coordination and working alongside 
Canadian ODA activities and other governmental development initiatives. 
3.3 DIF-H alternative delivery models 
The evaluation considered the options that were available to the Government of Canada at the 
time DIF-H was created, and noted that although a thorough analysis of the potential alternatives 
was not conducted, the decision to establish GCC as a mechanism for program delivery was 
appropriate.  
Although CIHR fulfilled the criterion regarding scientific rigour, and it had established similar 
programs through its world-leading work on knowledge translation, its organizational mandate 
would not have allowed it to support an extensive body of research commissioned outside of 
Canada. In regard to IDRC, it had experience in operating similar challenge funds and was the 
most appropriate existing institution that could have been selected as an implementing agency. 
However, it was assumed that an independent not-for-profit organization would provide greater 
flexibility and organizational responsiveness, which was considered important for the success of 
DIF-H in terms of funding innovation.  
With no ideal independent not-for-profit organizations available that met the criteria for DIF-H 
implementation, the decision to create GCC as a de novo organization was appropriate. The 
Government of Canada could have considered making its contribution to health innovation by 
providing funding to an existing challenge fund, such as that created by the Bill and Melinda Gates 
Foundation, but this would have created difficulties with regard to branding and would have 
reduced attribution to Canada. The analysis of delivery options made at the time DIF-H was 
created remains valid at the present time.  
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4 Core Issue 4: Achievement of expected outcomes 
This results section is structured according to the GCC logic model, which indicates the kinds 
of results that DIF-H should achieve (see Annex F). However, no specific targets (i.e., 
precise numbers) were set for the results expected, which makes it difficult to objectively 
determine whether DIF-H achieved its expected outcomes. As a result, judgements on 
whether DIF-H achieved its expected objectives are based on the evaluators’ view of what 
would be a reasonable achievement for a program of this type at this point of time.  
As explained in the methods section of this report, each source of evidence on DIF-H results 
has its limitations. These limitations mean that, for some of the results, it is not possible to 
determine an exact figure. Where this is the case, a range is given and the evaluators offer 
their best estimate, based on the rigorous triangulation of best evidence.  
We specifically highlight the lack of consistency in results reports, both internal and external. 
This is an important finding of the evaluation, not only a limitation of the study design. The 
implications of inconsistent performance measurement and inaccurate reporting practices 
are discussed as detrimental to DIF-H in the sections that follow. Specific attention to this 
issue is given in Section 4.5.  
In addition, it should be noted that no GCC performance data on the results produced by the 
Explorations and Hypertension grand challenges were received by the evaluators. It is 
understood that these were early projects funded in collaboration with partners; however the 
evaluators were not given data on them. The survey designed and fielded by the evaluators 
for this evaluation did collect data on Explorations and Hypertension.  
Finally, the reported results should be interpreted with an understanding that a long timeline 
to impact is expected for many of the DIF-H-funded projects; therefore further (positive or 
negative) results from current investments are expected in the future. 
4.1 Ultimate outcomes  
Main message: Ultimate outcomes have been achieved.  
• DIF-H-funded projects have saved and improved lives. For an innovation funding 
program at just over five years’ maturity, this is commendable.  
• Although precise figures cannot be pinpointed, triangulation of the best available 
evidence indicates the figures to be in the region of 8,689 lives saved and 160,000 lives 
improved over the course of the DIF-H program. 
4.1.1 Lives saved  
Considering conservative estimations, the evaluators consider that projects funded through 
DIF-H and managed by GCC have saved lives. The exact number cannot be precisely 
determined but the evaluators consider it to be between 209 and 16,415. Based on the 
available data, we estimate that the most appropriate single figure is 8,689.  
The evaluators were only able to identify 209 lives saved, based on validation of the GCC 
project database, despite it containing the same projects as the Strategy Roadmap, which 
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claims 8,689 lives saved. This is largely due to insufficient information or missing project 
data. Although information from the evaluators’ own GCC portfolio reviews suggests that 
Strategy Roadmap claims are plausible, the evaluators were unable to confirm exactly how 
the aggregated claims were calculated by GCC staff. This lack of transparency potentially 
undermines the credibility of DIF-H results. Moreover, lives saved claims made in the Results 
Dashboard are largely unverifiable because there is no information for some of the highest 
claiming projects.11 Therefore, the evaluators consider the figures presented in the Strategy 
Roadmap to be the best available estimate. 
Table 4: Number of lives saved claimed for each GCC data source 
Data source 





Roadmap    
(Current Mar-15) 




Annual Report  
(Current Mar-14) 
2015     
Annual Letter 
(Current May-15) 
Stars 958 948 38 x x 
TTS 7,796 80 0 x x 
Diagnostics 114 114 171 x x 
Explorations x x x x x 
SLAB x 7,547 0 x x 
Saving Brains x x x x x 
Global Mental 
Health 
x x x x x 
Hypertension x x x x x 
All grand 
challenges 
8,868 8,689 209 x ~10,000 
“x” denotes that no information was available. 
GCC monitoring and reporting: The lower figure represents the verifiable disaggregated 
results from the GCC project database, and the higher figure is a summation of the 
maximum claims for each grand challenge across all results claims documents. The number 
of lives saved claimed by GCC in each reporting source is shown in Table 4. 
Independent validation: Results from the survey show that 39% of GCC grantees claim that 
their projects saved at least one life. This is a much higher proportion than is claimed by 
GCC in its results documents. Although this may be partly due to reporting bias, it is highly 
suggestive of a significant impact on lives saved.  
                                               
11 For example the project delivered by JSI Research and Training Institute, which has 7,500 lives saved 
attributed to it. After obtaining clarification, it is understood that this is a USAID-managed project that was co-
funded by GCC; 100% of the results have been attributed to all donors.   
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Qualitative findings from the Peruvian in-person site visits also indicate that DIF-H-funded 
projects have saved lives, and there were reports from grantees that GCC project officers 
amended claims to be more conservative. 
4.1.2 Lives improved 
Considering conservative estimations, the evaluators consider that projects funded through 
DIF-H and managed by GCC have improved lives. The exact number cannot be precisely 
determined but the evaluators consider it to be between 136,905 and 252,452. Based on the 
available data we estimate that the most appropriate single figure is 160,313.  
The higher figures found by the evaluators in the project database compared to those of the 
Strategy Roadmap are due to different interpretations of what constitutes lives improved. 
This suggests that GCC is conservative in its calculation of lives improved, and the maximum 
GCC claims for lives improved are likely to be a fair estimate. This equates to a summation 
of the highest claims for each grand challenge reported in the Dashboard and Strategy 
Roadmap: 160,313. 
Table 5: Number of lives improved claimed for each GCC data source 
Data source 





Roadmap    
(Current Mar-15) 






2015     
Annual Letter 
(Current May-15) 
Stars 44,853 38,329 194,982 x x 
TTS 106,511 89,627 38 x x 
Diagnostics 3,260 3,260 3,798 x x 
Explorations x x x x x 
SLAB x 117 27,341 x x 
Saving Brains x 3,171 0 x x 
Global Mental 
Health 
x 2,401 26,293 x x 
Hypertension x x x x x 
All grand 
challenges 
154,624 136,905 252,452 x ~150,000 
‘x’ denotes that no information was available. 
GCC monitoring and reporting: The lower figure represents the claims made in the 
Strategy Roadmap, and the higher figure represents the evaluator’s analysis of individual 
project reports in the GCC project database. The number of lives improved claimed in each 
GCC reporting source is shown in Table 5. 
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Independent validation: Results from the survey show that 77% of GCC grantees claim that 
their projects improved at least one life. Following the same pattern as lives saved, this is a 
much higher proportion than is claimed by GCC in its results documents, which is highly 
suggestive of a significant impact on lives improved.  
Qualitative and observational findings from the Peruvian case studies also indicate that DIF-
H-funded projects have improved lives.  
4.2 Intermediate outcomes  
Main message: Intermediate outcomes have been achieved. 
• Triangulation of the best available evidence indicates that approximately 3.69 million 
target beneficiaries accessed innovative health products and services developed using 
DIF-H funding. 
• The projects funded by DIF-H have had a positive impact on health policies, training 
practices, and health systems.  
4.2.1 Access to innovations 
The evaluators estimate that between 3.69 million and 5.28 million target beneficiaries 
accessed an innovative health product or service that was developed using DIF-H funding. 
GCC monitoring and reporting: The lower figure represents the GCC claims in the Strategy 
Roadmap, and the higher figure is a summation of the maximum claims for each grand 
challenge across all results claims documents. The number of target beneficiaries who 
accessed an innovative health product or service, for each data source, is shown in Table 6.
Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management  23 
Table 6: Number of target beneficiaries who accessed an innovative health product or 
service, for each data source  
Data source 
Internal monitoring data Official reports 
GCC Dashboard 
(Current Jun-15) 





2015          
Annual Letter 
(Current May-15) 
Stars 76,151* 1,248,122 619,707 x 
TTS 1,729,608 137,898 x x 
Diagnostics 1,015,717 1,015,717 x x 
Explorations x x x x 
SLAB x 1,233,984 555,349 x 
Saving Brains x 4,925 x x 
Global Mental 
Health 
x 46,488 20,427 x 
Hypertension x x x x 
All grand 
challenges 
2,821,476 3,687,134 1,195,483 x 
 ”x” denotes that no information is given. 
*This number only includes improved access from the six top performing Stars projects. 
A review of the GCC database reveals that the majority of claims appear plausible. However, 
the Dashboard attributes access by 1.5 million target beneficiaries to the JSI Research and 
Training Institute project. Therefore the evaluators consider the Strategy Roadmap to be the 
most conservatively reliable estimate.   
Independent validation: Results from the survey show that 33% of GCC grantees claim that 
their projects increased access to products/services. Since the GCC claims for increased 
access are high, while at the same time the survey suggests that only a third of projects 
increase access, this would mean that the few projects that increase access do so 
considerably. A review of the top performing projects reveals that this is indeed the case, 
with the vast majority of improved access claims being attributable to only a few projects.  
The Peruvian case studies also captured compelling evidence that DIF-H-funded projects 
have increased access to innovative products funded through DIF-H. 
4.2.2 Positive impact on health policies, training practices, and health 
systems  
GCC monitoring and reporting: The annual report claims that DIF-H-funded projects have 
influenced 20 health-related policies/regulations in developing countries. However, a review 
of the projects database reveals that 61 projects have had a positive impact on health 
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polices, training practices, or health systems. The extent of this positive impact was highly 
variable, ranging from incremental small-scale changes to national policy reforms with 
important health care implications. However this review also highlighted projects that had the 
potential for unintended and damaging impacts on health systems. These are discussed 
further in Section 5.5.3.2. 
Independent validation: The more recent, and higher, claims in the project database are 
supported by results from the survey, in which 18% of GCC grantees claim that they have 
changed health polices for the better, 24% improved training practices, and 19% had a 
positive impact on health systems. 
During the Peruvian case studies, the evaluators heard compelling evidence that the findings 
from DIF-H projects had resulted in important changes to national health policies and 
procurement practices.  
4.3 Immediate outcomes  
Main message: Immediate outcomes have been achieved. 
• DIF-H investments have created work and funding opportunities to address global health 
through innovation. 
• In accordance with the DIF-H theory of change, GCC has made successful efforts to 
promote organizational and project partnerships, build networks, and develop capacity to 
support health innovation projects.  
• These activities have contributed to increased knowledge and awareness of a positive 
international Canadian brand related to global health innovation. 
4.3.1 Work and funding opportunities to address global health through 
innovation 
GCC claims it has created 578 jobs in Canada and 7,018 jobs in LMICs. The evaluators 
were not able to validate these claims, partly because the indicator used by GCC is 
conflated, as it also includes livelihoods improved in the reported numbers. However, these 
numbers are plausible based on the survey responses, as GCC grantees claim that 13% of 
projects created jobs in Canada and 49% created jobs in LMICs. 
GCC has awarded $42 million of DIF-H funding to Canadian institutions undertaking health 
innovation projects, and around $100 million to LMIC institutions for the same purpose. 
Institutions in high-income countries (HICs) other than Canada received $24 million. The 
proportion of DIF-H funding allocated by region is shown in Figure 5.  
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Figure 5: Proportion of DIF-H funds allocated by region 
 
 
In addition to DIF-H funding, GCC has also leveraged and secured venture capital funding 
amounting to more than the original DIF-H investment. This has been, or will be, directed to 
further health innovation projects.  
Importantly, the survey demonstrates that the majority of DIF-H-funded projects (78%) were 
specifically developed in response to GCC grant calls, rather than being adapted or 
repurposed. This suggests that DIF-H funding is not fungible with other donor grant calls, 
and represents a relatively unoccupied space.  
4.3.2 Promoting partnerships, networks, and capacity to support health 
innovation 
GCC’s achievements in increasing the adoption of the grand challenge approach in other 
countries (Israel, Peru, India, Brazil, and Thailand), and contributing to enhancing the 
approach in the United States, are also to be applauded. Although the new grand challenge 
models are in their early stages, they will likely result in further funds and jobs focused 
toward health innovation projects by national governments. 
In accordance with the DIF-H theory of change, GCC has made successful efforts to 
promote partnership between health innovators in HICs and LMICs (North–South 
partnership), and among innovators in LMICs (South–South partnership). This was mainly 
achieved by stipulating that HIC applicants must have a partner from a LMIC. The survey 
found that 65% of GCC-funded projects involved a collaboration between the primary 
grantee and one or more partners. In 16% of projects at least one of these partners was from 
a Canadian institution, and in 30% of projects these partnerships were between individuals 
that had not previously worked together.  
GCC has also successfully supported networking and capacity building of its grantees 
through its targeted challenge-specific communities of innovators, community meetings, and 
annual grand challenges meetings. Based on GCC-administered feedback surveys that were 
validated by the evaluators, these meetings were largely well received and deemed to 




LMIC Canada Other High-Income country
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According to the grantee survey, 85% of GCC grantees benefited from at least one 
networking opportunity, and 69% were either satisfied or very satisfied with the networking 
opportunities provided. The survey also shows that 91% of GCC grantees were enabled in at 
least one type of capacity. Additionally, 69% of projects funded by GCC resulted in at least 
one innovator being trained, while 13% trained 10 or more innovators, although 30% did not 
train any innovators.  
The case studies in Peru further confirm these successes, with several grantees reporting 
that their capacity was strengthened and commenting on the importance and usefulness of 
GCC networking events. 
4.3.3 Increased knowledge and awareness of a positive international Canada 
brand 
Increased knowledge and awareness of a positive international Canada brand has largely 
been achieved through GCC’s concerted communication and international engagement 
efforts. These have included working with other international donors to form targeted 
challenge-specific global partnerships; helping create and enhance other countries’ grand 
challenges models; engaging with the Canadian diaspora to encourage it to support the 
projects funded by DIF-H; and publishing and disseminating achievements through 
publications, articles, and social media.  
These international engagement efforts have also provided Canada with a useful diplomacy 
tool, especially in countries that are forming grand challenge family models. One diplomat 
interviewed by the evaluators described how GCC was particularly good at engaging with 
Canadian official representatives abroad, and said that other development programs could 
learn from it to improve their connectedness with Canadian foreign relations. This willingness 
of GCC to cooperate and play a leadership role in international global health efforts has also 
been noted by other grantees and independent key informants.  
These activities have positioned Canada as a strong player in the global arena of health 
innovation, even though the funding provided to DIF-H is relatively small compared to other 
Canadian ODA and international investments. Therefore, DIF-H’s strategy of acting as a 
catalyst for global health innovation appears to have been realized; it was colloquially 
suggested by one independent interviewee that “DIF-H really punches above its weight.” 
However, there is some concern from key informants that the Government of Canada does 
not receive enough credit for DIF-H achievements, given its investments in DIF-H. GCC has 
been careful to ensure that funding by Canada is acknowledged in all of its communication, 
and a visibility agreement between GCC and DFATD is planned to ensure that the 
government gains appropriate recognition. However, this agreement has not yet been 
developed. While this is an area for debate and potential negotiation, the survey found that 
67% of GCC applicants knew that GCC grants were funded by the Canadian government 
(8% thought GCC was funded by the Bill and Melinda Gates Foundation). Furthermore, it 
was mandated that DIF-H should increase knowledge about, and branding of, Canada as a 
country, not the government, and this has been achieved. 
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4.4 Outputs produced 
Main message: DIF-H has produced outputs. 
• DIF-H-funded projects have developed a large number of innovations.  
• Grantees have been successful in publishing results in peer-reviewed journals, sharing 
their knowledge, and securing patents for their innovations.  
• The projects funded by GCC appear to be relatively successful at scaling to further 
development or implementation. However, these high success rates suggest that DIF-H 
may be unduly risk averse.  
• Using DIF-H funds, GCC has effectively leveraged funds and secured financial 
investments that exceeded the total DIF-H budget provided by the Government of 
Canada. 
4.4.1 Innovative prototypes or service delivery models developed 
The most recent report of the number of innovations developed comes from the GCC Annual 
Report 2013–2014, which claims that 346 innovations have been developed. This definition 
of innovation includes prototypes, service delivery models, and models developed through 
economic modelling.  
This number appears quite high given that many projects have yet to finish and at the time of 
this GCC annual report there were fewer investments in GCC’s portfolio. However, these 
success rates appear plausible based on analysis of the database and survey. Within the 
database approximately 20% of projects failed to demonstrate proof-of-concept,12 while GCC 
grantees reported in the survey that only 2% of projects failed to reach proof-of-concept.  
While this success rate can be considered impressive, it does not appear to be aligned with 
GCC’s vision for bold innovations with big impact. Authors argue that the pursuit of 
innovation needs to be risky, and therefore a large number of attempts at innovation are 
likely to fail (Al-Dabal, 1998; Hargadon et al., 2000). If this level of risk is not accepted, truly 
innovative and transformational ideas are less likely to be found (Perrin, 2002). Zider (1998) 
suggests that “on average, good plans, people, and businesses succeed only one in ten 
times” (Zider, 1998, p. 136). This is not to suggest that a laissez-faire approach to investment 
should be acceptable and that calculated risk is not necessary, but rather to emphasize that 
traditional performance assessment mindsets that failures are inherently bad should not 
apply to innovation. Therefore GCC may wish to reconsider its selection criteria to be more 
risk-tolerant.  
Nevertheless, the fact that the majority of DIF-H-funded projects were specifically developed 
in response to GCC grant calls, rather than being adapted or repurposed, suggests that DIF-
H is encouraging novel ideas.  
                                               
12 ‘Proof-of-concept’ refers to the stage of innovation product/service development where an initially unproven 
concept or idea has been tested through a pilot stage, and has been shown to be effective during small-scale 
investigations in a relatively controlled environment.  
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4.4.2 Publications, patents, and knowledge sharing 
Based on the outcome statements in the database, GCC grantees have published a total of 
185 academic publications and secured 57 patents or patents pending. These publications 
and patents come from 9% and 6% of all projects, respectively, including those that are 
incomplete or that have failed to demonstrate proof-of-concept. These database findings are 
supported by the survey, which claims even higher rates of publications and patents 
(including patents pending) per project: 34% and 26%, respectively. 
In addition to publications, both the GCC database and the survey reveal that the majority of 
GCC grantees have also shared their knowledge through less formal mechanisms, such as 
conference presentations, workshops and seminars, and non-peer-reviewed journals, 
working papers, newspapers, blogs, and other social media.  
4.4.3 Innovative prototypes or service delivery models transitioning to scale  
Of the projects that demonstrated proof-of-concept (n=20813), 20% transitioned to scale 
through GCC grants or other funding mechanisms. Transitioning to scale refers to when a 
pilot or proof-of-concept study demonstrates success and receives further investment to 
expand development or implementation.  
Projects from the Diagnostics portfolio have been most successful at transitioning to scale 
(40%), followed by the targeted challenges projects (30%), with the Stars projects being least 
likely to transition to scale (17%). This pattern is to be expected given that the Diagnostics 
and targeted challenge projects are generally larger and less risky investments that are often 
further along the development pipeline at the time of investment. However, according to 
innovation literature (Zider, 1998; Perrin, 2002), even the transition to scale rate of 17% for 
the Stars projects is good, especially given their low-investment high-risk profile. 
4.4.4 Venture capital secured and funds leveraged  
Using DIF-H funds, GCC has secured venture capital through the Global Health Investment 
Fund, for which they provided the anchor investment ($9.8 million). This fund was created for 
private sector companies and individuals to invest in global health innovations. The value of 
the fund is now over $96 million. Engaging with such an innovative financing mechanism 
represents a potentially important pool of funding for future investments in late-stage global 
health innovations.  
Through co-financing, the total value of GCC’s funded projects is significantly higher than the 
total DIF-H budget. GCC achieved this through:  
(i) Program-level co-funding — forming international partnerships with other donors and 
development agencies, with whom GCC shares the results, to support the grand 
challenges programs. This effectively pools funds to support common causes. The 
majority of this funding went to the targeted challenges portfolios.  
(ii) Project-level co-funding — requiring matching funds from project partners for some of 
their project-specific investments. Matching funds could come from public or private 
                                               
13 This excludes projects in the TTS portfolio. 
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sources. The majority of matching funding went to the innovator-defined challenges 
portfolios and was procured by the grantees themselves. 
It should be noted that most co-financing was not channelled through GCC and did not 
support GCC overheads. Rather, it went directly from the co-financing donor to project 
grantees. A breakdown of the funds leveraged for each grand challenge is shown in Table 7. 
Table 7: Breakdown of project funds leveraged 
Program areas Grand challenges Funding leveraged (C$) 
Innovator-defined challenges 







Saving Brains 6,661,130 
Global Mental Health 1,297,946 
Hypertension 4,006,638 
Total  56,274,737 
Total  172,857,661 
 
4.5 Monitoring and reporting of results 
Main message: GCC monitoring of projects and reporting of results requires 
improvement. 
• GCC has iteratively developed a minimal effort monitoring system that is appreciated 
by its grantees.  
• The monitoring system is not sufficiently systematic, and indicators need strengthening.  
• GCC’s reporting of results claims requires greater attention to scientific rigour, 
transparency, and consistency. The current approach damages the credibility of claims 
by allowing skepticism of genuine results. 
 
IDRC and GCC expended considerable effort in developing the original Treasury Board–
defined objectives for DIF-H into monitoring indicators. This included developing the 2011 
DIF-H Learning Monitoring and Evaluation Framework (LMEF) and the DIF-H theory of 
change. GCC subsequently tailored these DIF-H monitoring frameworks, to turn them into 
the Results Monitoring and Accountability Framework (RMAF) and logic model, which 
measures results of GCC-funded projects. GCC also developed grand challenge-specific 
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theories of change. This level of work and reflection is commendable and has responded to 
one of the formative evaluation recommendations.14  
However, GCC’s current project monitoring system requires strengthening. Some indicators 
should be revised or replaced because they are not sufficiently precise or mutually exclusive, 
and others are subjective. Examples include “jobs created and livelihoods improved,” 
“intermediary access to innovations,” “use of innovations,” and “lives improved.” “Lives 
improved” is particularly problematic because it overlaps with “target beneficiary access to 
innovations” and “use of innovations,” and is entirely subjective. This was exemplified by the 
different interpretations the evaluators identified, as regards “lives improved” and “beneficiary 
access to innovations.” There also seems to be some confusion over the terminology used to 
structure indicators: for instance, what constitutes an activity or progress indicator or output, 
and the difference between immediate, intermediate, and ultimate outcomes.  
The only consistent source of project outcome data has been grantees’ self-reported results. 
GCC uses a consolidated framework to collect monitoring data from the grantees: the RMAF. 
This was one of the formative evaluation recommendations that were followed. However, not 
all grantees systematically report project outcomes using the RMAF, which means results 
from these projects cannot be reported in the current logic model framework. These self-
reported claims do undergo some plausibility checks by GCC project officers and Scientific 
Advisory Board subcommittees during portfolio reviews, but often there is insufficient time 
and data available to properly interrogate grantee claims. These issues were raised in the 
formative evaluation but have not been fully addressed. To improve the review process, a 
consistent format that provides sufficient data to properly review claims should be developed.  
To ensure the validity of the grantee results claims, data validation is ideally required. The 
results of some projects have undergone scrutiny through a review as part of the process of 
publishing results in academic journals and presenting at conferences. GCC’s efforts at 
encouraging this should be commended because it not only provides an external source of 
verification and disseminates findings, but also helps develop grantees’ capacities, builds 
their research networks, and advances scientific knowledge.  
Internally, GCC has validated results on an ad hoc basis. However, this appears to be 
becoming more routine, which will significantly improve the trust that can be placed in the 
results claims. For instance, GCC has recently starting conducting field visits to validate 
grantee claims. It also conducts random financial spot audits to ensure grantees’ fiduciary 
transparency and performance. In addition, IDRC has conducted one field visit in Kenya and 
one performance audit (both in 2014). IDRC also commissioned an independent field visit in 
Peru as part of the summative evaluation. These additional data collection activities are 
important, but they should be integrated into a more systematic monitoring approach.  
However, all these data validation considerations must be balanced because there is a 
trade-off between the robustness of a monitoring system and the level of effort and cost 
required. GCC acknowledges that it operates a lean monitoring system, especially for its low-
investment projects. This not only saves GCC money and resources, but allows innovators to 
spend more of their time and grant on developing innovations than reporting to GCC. Based 
on the survey, it appears that the vast majority of GCC grantees appreciate this monitoring 
                                               
14 The formative evaluation recommended GCC improve its measurement of progress and success (theme 7) and 
develop a theory of change for the scaling up of projects and corresponding monitoring plans (theme 8).  
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approach: 84% reported the GCC monitoring was about right, 11% said it was too much, and 
4% said it was too little. 
Regardless of the indicator and data quality, GCC’s reporting of results claims requires 
greater attention to scientific rigour, transparency, and consistency. The current approach 
damages the credibility of claims by allowing skepticism of genuine results. For public 
engagement purposes, the simple and digestible key results claims are acceptable, but this 
must not replace the scientific reporting of results to specialized audiences who require much 
more detailed, transparent, and auditable results formats, in order to be able to verify claims. 
Disaggregated results, annexes detailing methodologies and calculations, and justifications 
of any changes in claims should be provided. Furthermore, results claims should only be 
released when they have been finalized and are supported with sufficient information to 
permit appraisal.  
4.6 Results discussion 1: Questioning the DIF-H theory of change  
The methodology running through the evaluation design allows us to test several 
assumptions within the DIF-H theory of change. These findings will be useful for refining the 
DIF-H theory of change and thereby improving program delivery, as well as informing the 
wider debate on grand challenges development modalities.  
4.6.1 Funding innovators in developing countries 
A defining feature of DIF-H’s approach to funding innovation is a willingness to invest in 
innovators in developing countries (60% of DIF-H grant funds were allocated to LMICs). This 
is based on the implicit belief that innovators in developing countries have the local 
knowledge and expertise to address their countries’ health issues. This opportunity for 
developing countries to establish ownership of their health problems has been applauded by 
grantees and key informants alike, and is a central thrust of more recent international 
development thinking (WHO, 2013b) (although Canadian organizations like IDRC have been 
using this approach for decades).   
Findings from the survey show that this premise is well founded. As shown in Table 8, 
projects that funded innovators in LMICs were much more likely to result in lives saved, lives 
improved, and increased access to innovative products than projects that funded innovators 
from HICs. This was true even though many projects funded in HICs were implemented in 
LMICs. In most cases, projects funding innovators in low-income countries performed better 
than projects funding innovators in middle-income countries. Furthermore, this pattern also 
holds true when considering the immediate outcome measures: adoption of health policies, 
health systems strengthened, and training practices improved.  
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Table 8: Influence of respondents’ primary institution location on project outcomes 
 
All projects performed very well in regard to developing innovations and demonstrating proof-
of-concept. However, projects funding innovators from HICs were more likely to result in 
patents and peer-reviewed publications. This is perhaps not surprising given the recognized 
lack of resources and capacity for publishing and protecting intellectual properties in 
developing countries (Nuyens, 2005). However, it is important to note that innovators in 
LMICs showed a strong appetite for knowledge sharing by being more likely to engage other 
knowledge users through less formal channels, such as seminars and conferences.  
4.6.2 Funding less-experienced innovators  
Aligned with the approach of funding innovators in developing countries is a willingness to 
fund less-experienced innovators. This is based on the belief that there is a wealth of 
important ideas that could improve global health, and research and development 
powerhouses are not the sole purveyors of such ideas. Rather, anyone, anywhere, could 
have potentially transformative ideas that are waiting to be tapped. This approach has been 
applauded by grantees and key informants. Although DIF-H does not fund a majority of 
early-career innovators, findings from the survey show that it funds roughly equal proportions 
of early-, mid-, and senior career-level innovators. 
However, findings from the survey suggest that this may not be the most immediately 
productive approach. Self-identified senior career innovators consistently reported higher 
rates of ultimate, intermediate, and immediate outcomes and outputs than mid- and early-
career innovators (except as regards lives improved, for which mid-level innovators reported 
the highest). Mid-level innovators reported higher rates of lives saved and lives improved 
than early-career innovators, but were generally similar across all other indicators, except for 
peer-reviewed publications, for which early-career innovators were more successful. The 
number of previous grants reported by innovators appears to have had no effect on the 
outcomes and outputs of their projects.  
While this confirms common perceptions that projects led by more experienced individuals 
will be more effective, it does not necessarily contradict the DIF-H theory of change. This is 
because early-career innovators did indeed have good ideas and also effectively ran their 
projects so that they resulted in positive health outcomes and outputs. Furthermore, the 
survey only captures the frequency of projects reporting ultimate and intermediate outcomes, 
not the total number achieved by each project, so it is not known whether these gains were 
incremental or transformative. Therefore the approach adopted by GCC of having an equally 
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24.3 64 27.8 14.3 21.8 16.5 
Upper and lower 
middle-income 
52.6 80 31.3 19.6 29.5 22.3 
Low-income 
 
50 89.7 44.6 24.8 21.8 21.8 
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4.6.3 Funding a mixture of small and larger investments  
Another feature of DIF-H project funding is GCC’s decision to fund a mixed portfolio of small 
and larger investments. The small investments are more numerous and tend to be valued at 
around $100,000. These are the Stars projects, which represent the venture capital style 
high-risk, low-dollar-value investments. The targeted challenge projects are usually mid-
dollar-value investments of around $250,000, and represent higher investments in more 
established ideas or organizations. Finally, GCC makes a few high-dollar-value investments 
of between $300,000 and $2.8 million, which tend to be well-established, lower-risk targeted 
challenge projects and projects that are transitioning to scale. The strategy behind this is 
essentially one of spreading bets: supporting the development of untested and risky but 
potentially transformative innovations, as well as more conservative and proven innovations.  
Based on an analysis of the GCC database, there appears to be no consistent pattern in the 
number of ultimate, intermediate, and immediate outcomes and outputs that a project 
achieves when disaggregated by different values of project funding. In the absence of any 
clear patterns to show otherwise, the current approach seems reasonable. 
4.6.4 Supporting project partnerships  
A key component of the DIF-H theory of change is supporting partnerships in projects. The 
evaluators found that GCC is indeed effective at promoting partnership and networking. 
Partnerships between HICs and LMICs are thought to increase the likelihood of project 
success by combining the local expertise of the LMIC partner with the presumed greater 
capacity and research experience of the HIC partner (Costello and Zumla, 2000). However, 
GCC does not require LMIC institutions to have a partner, although they may choose to have 
a partner from an HIC or LMIC.  
The effects of partnership on project outcomes were tested through the grantee survey. All 
respondents who received funding were requested to indicate if they had partners in their 
project proposal, and to provide details of the type of partners that were involved in their 
project (up to a maximum of three).  
Projects that did not involve partnership were more likely to result in lives saved, and slightly 
more likely to result in lives improved (50% as against 35.9%, and 77.1% as against 75.6%, 
respectively). However, projects that did involve partnerships were more likely to result in all 
intermediate and immediate outcomes and outputs. Therefore, although the negative 
influence of partnership on ultimate outcomes is surprising, the positive influence on all other 
indicators reinforces the DIF-H theory of change and the generally held view that research 
partnerships stimulate impact.  
This pattern may be explained by the fact that it is relatively early to expect clear 
associations to occur in ultimate outcomes (even for completed projects), whereas patterns 
in intermediate and immediate outcomes may be more established and reliable. Another 
explanation, which is well supported by other research and evaluation, is that impactful 
partnerships require meaningful engagement, which takes time and effort (Cargo and 
Mercer, 2008; Jagosh et al., 2012; CIHR, 2013). The result may mean that partnered DIF-H 
projects are earlier on the trajectory to impact. However, it is also possible that LMIC 
innovators who chose not to have HIC partners did so because they were already in a strong 
position and therefore did not need, or would not greatly benefit from engaging a Northern 
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partner. By contrast, the LMIC partners who were approached by an HIC innovator may have 
been in a weaker initial position.  
This second supposition is supported by a partnership-specific breakdown of survey findings. 
LMIC-led HIC partnerships (where the primary grantee is based in an LMIC and the partner 
is based in an HIC) were the most likely to result in all ultimate and intermediate outcomes. 
Furthermore, compared to LMIC-led projects with no partnership, they were more likely to 
result in all indicators, except lives saved, which was equally likely to occur. 
LMIC–LMIC partnerships were more likely to result in some outcomes than HIC-led LMIC 
partnerships, but not others. It is not clear why HIC–HIC partnerships were reported, as the 
evaluators were under the impression that these were not permitted under grant parameters. 
Regardless, they were the least effective type of partnership in terms of likelihood of resulting 
in ultimate and intermediate outcomes.  
In agreement with the findings in Section 4.6.1. above, these results indicate that 
partnerships established by primary grantees from LMICs are likely to be more effective in 
terms of health outcomes than partnerships established by primary grantees from HICs; HIC-
led partnerships are only more effective at producing peer-reviewed publications and 
patents. These data support the hypothesis that LMIC knowledge and ownership are 
important for development programs to have an impact (Binka, 2005). 
Therefore, DIF-H’s approach of not requiring LMIC innovators to have a partner, but 
requiring HIC innovators to have an LMIC partner, appears to be well founded. However, 
based on these results, DIF-H may wish to consider only accepting partnerships where the 
primary grantee is based in an LMIC.  
4.6.5 Supporting capacity building 
The DIF-H theory of change explicitly aims to strengthen innovators’ capacity in order to 
sustainably develop innovation platforms in Canada and LMICs. As presented in Section 4.3, 
GCC appears quite effective at developing the capacity of its grantees. However, to 
understand the implications of this capacity building, it is necessary to look at the data in 
more detail.  
According to the survey, 92% of grantees reported they improved their capacity through the 
DIF-H grant. The most commonly built capacities were technical skills, project leadership 
skills, and management skills (75%, 66%, and 62%, respectively). The least commonly built 
capacities were business skills, winning further project funding, and skills supporting 
transitioning to scale of innovations (29%, 30%, and 34%, respectively). This is problematic 
because the less commonly built skills are the capacities that innovators will require to 
graduate from proof-of-concept funding to sustainably and independently fund their 
innovations.  
Low-income country innovators were slightly more likely to have their capacities built in 
nearly all types of capacity, closely followed by innovators from HICs, then middle-income 
countries. However, projects that were primarily based or implemented in HICs were more 
likely to train other innovators, followed by middle-income countries, then low-income 
countries. This is also problematic because LMICs are in the greatest need of well-trained 
innovators.  
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This suggests that although GCC is effective at developing innovators’ capacity, it needs to 
focus more on building capacities to support scaling of innovations. GCC should also try to 
understand why projects in low-income countries are less likely to train innovators.  
Perhaps surprisingly, results from the survey show that projects involving partnerships were 
only slightly more likely to build at least one capacity than projects not involving partnership. 
Furthermore, partnerships between LMIC institutions were slightly more likely to build at least 
three types of capacity than partnerships between LMIC and HIC institutions. However, 
partnerships between LMIC institutions were clearly the most effective type of partnership for 
building all types of capacities (except technical skills and winning further project funding).  
These findings reinforce the argument that projects involving and led by LMIC innovators are 
better investments than projects led by HIC partners. It also suggests that if GCC decides to 
address the weaknesses in developing innovation scaling capacities, this attention would be 
best focused on projects led by, or only involving, LMIC innovators. One possibility would be 
to provide LMIC innovators with small amounts of additional funding earmarked for specific 
training or capacity development purposes. 
4.6.6 Does integrated innovation work? 
Integrated innovation is key to the DIF-H theory of change. It involves the “coordinated 
application of scientific/technological, social and business innovation to develop solutions to 
complex challenges. This approach does not discount the singular benefits of each of these 
types of innovation alone, but rather highlights the powerful synergies that can be realized by 
aligning all three to address a single challenge” (GCC, 2010). By undertaking integrated 
innovation, it is believed that a higher proportion of innovations will transition to scale and be 
available to beneficiaries who can reap the health benefits.  
The findings from this evaluation show that DIF-H-funded projects have a very high success 
rate in terms of resulting in innovations and demonstrating proof-of-concept. A significant 
proportion of these also go on to transition to scale. This suggests that GCC’s integrated 
innovation approach may contribute toward the development of innovative products and 
services.  
However, the GCC database shows that of the innovative products and services that 
transition to scale, the majority do this through public sector channels. The apparent difficulty 
in scaling innovations through the private sector is attested to by key informants and case 
study participants: both report that there is a lack of interest from the private sector, and 
innovators do not know how to go about finding private sector investors and scaling through 
private channels. This qualitative evidence is further supported by survey data, which show 
that the capacity that is most lacking is business skills, and the second most lacking 
networking opportunities are networking with potential investors.  
This suggests that although integrated innovation is effective in supporting innovation 
development through the public sector, scaling through the private sector remains a 
bottleneck. Therefore, while GCC is effective at engaging with the private sector, GCC 
grantees are not. Potential solutions include focusing capacity development activities on 
private sector scaling skills and increasing networking opportunities with potential private 
sector partners.  
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4.7 Results discussion 2: The importance of considering future 
results  
Innovation is a long-term goal, and one would expect that a comprehensive measurement of 
the results achieved by all DIF-H projects would not be possible for another 10 years (Morris, 
Wooding, and Grant, 2011). This summative evaluation is required to assess the results that 
DIF-H has achieved in the last five years, but it should be recognized that some of the 
projects funded by DIF-H will not achieve all their outcomes (either positive or negative) for 
many years to come.  
It is therefore surprising that so many of the projects funded by DIF-H are already achieving 
ultimate and intermediate outcomes. As presented in the above sections, GCC is already 
reaping significant health gains from relatively recent investments.  
To ensure an appreciation of the potential for future gains from current investments, GCC 
has endeavoured to predict the impact of a few of its top performing projects using novel 
projection methodologies. These are a new and important addition to GCC’s impact-tracking 
efforts that can enumerate the expected number of lives saved and lives improved that an 
individual project can achieve by 2030. The methodology is still being refined and must be 
considered as a work in progress, but so far projections for 10 of the 77 current TTS 
investments are predicted to result in more than 500,000 lives saved and over 7.5 million 
lives improved by 2030.  
Nevertheless, the path to innovation is recognized as uneven, with apparently 
underperforming projects achieving unexpected success, and the most promising projects 
failing at the last hurdle (Perrin, 2002). Therefore any projections are questionable and 
should be treated with caution. It is also important to note that the evaluators have not 
validated these projections, and they include them only as a conceptual aid to consider the 
potential for future impacts.  
However, GCC’s attempts to develop methodologies to project future impacts from 
innovations are prudent, and could be important for the future of the field of innovation 
impact measurement. As the methodologies mature, they could become important tools for 
estimating future impacts or making more informed investment decisions. 
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5 Core Issue 5: Demonstration of efficiency and economy  
5.1 Economy  
Demonstrating economy “involves assessing whether minimal or fewer resources could have 
been used without compromising the delivery of expected outputs and outcomes” (TBS, 
2009). In order to determine if DIF-H has been economical, the evaluation assessed what 
attempts at economy have been made by DIF-H, and if these actions resulted in an 
acceptable level of economy.  
 
Main messages: An acceptable level of economy was achieved by DIF-H. 
 
• The evaluation found evidence of economy achieved when setting up and 
implementing DIF-H. 
• However, some of the DIF-H economies may not actually be net savings for the 
Government of Canada, because the services provided by CIHR and IDRC appear to 
be undervalued.  
• Due diligence was applied to ensure that economy was an ongoing process. 
 
The decision to establish DIF-H as a consortium provided opportunities for economies to be 
made by the Government of Canada; these opportunities have largely been seized. The DIF-
H consortium provided its services to set up the DIF-H implementing arm, GCC, at a 
favourable rate that represented a strategic investment for the government.  
To deliver their respective roles and responsibilities, IDRC was allocated $4.5 million, and 
CIHR’s public budget allocation was increased by $0.9 million. The cost of establishing GCC 
as a stand-alone organization without the nurturing support of the other consortium members 
would have been higher.  
However, the budget allocated to IDRC and CIHR seems to underestimate the costs incurred 
by these consortium members. As public institutions, CIHR and IDRC were tasked with 
supporting the creation and functioning of DIF-H. It was economical for the Canadian 
government to take this approach as it already funds IDRC and CIHR. However, the 
evaluation was not able to calculate the real financial and resource costs to these institutions 
as neither institution has a system that enables tracking of how much money, time, and 
resources were spent on supporting DIF-H.  
When assessing DIF-H’s economies it is critical to take a closer look at GCC’s operational 
costs: first, because GCC implements over 95% of the DIF-H budget, and second, because 
the finances provided to the other consortium members are not an accurate representation of 
their true costs. In summary, GCC put a lot of effort into achieving favourable economies, 
and all the inputs it acquired are on track to be fully spent.  
Examples of GCC efforts to ensure economy include: 
1. Minimization of procurement costs. GCC entered into an agreement with the Sandra 
Rotman Centre and University Health Network to provide work space at the University 
Health Network premises, as well as human resources and other administrative services 
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(GCC, 2012). The review of these operational agreements concluded that the 
operational agreements are reasonable, necessary to deliver the project, and based on 
market conditions. When possible, GCC set up its own account with suppliers to reduce 
the amount of administrative services provided by University Health Network and 
therefore exercise better control over its expenses.15 GCC also contracted services 
following competitive tendering process (i.e., for the technical platforms) ensuring that 
the selection of service was based on qualitative and financial assessment of proposals.  
2. Remuneration controls for GCC senior staff. The GCC board approved GCC’s 
existing processes for setting remuneration packages for staff. The GCC board 
concluded that the processes and rates are reasonable.   
3. Mechanisms to leverage significant inputs were put in place. The evaluation found 
that GCC has been able to leverage significant technical support at no or very little cost 
by using its networks and influence.  
4. All acquired inputs were utilized, absorbed, and needed. At 10% of operational 
costs, the evaluation team estimates that GCC is a lean organization, and clearly needs 
and utilizes all the resources that it acquires (MoneySense, 2013).  
5.2 Efficiency  
As suggested by the Treasury Board guidance on “Assessing Program Resource Utilization 
When Evaluating Federal Programs” (TBS, 2013), we have undertaken an assessment of 
efficiency based on a cost–utility analysis. This method provides an assessment of program 
resource utilization in light of the program’s worth.  
DIF-H’s allocative efficiency ratios are estimated by considering the lives saved that DIF-H 
has currently achieved (as presented in Section 4) over the costs of inputs. Given the 
possible range for lives saved, the evaluators’ best estimates are used.   
The total cost of DIF-H’s inputs is based on the total amount spent by DIF-H. This scenario 
considers the current investments for the results achieved but does not consider the budget 
not yet spent (although this may be allocated). Since this figure should cover the total cost of 
DIF-H to the Government of Canada, we have included the total amount of funds engaged 
by GCC, including the research support activities, plus the DIF-H earmarked budgets for 
IDRC and CIHR. The additional funds provided by DFATD and the UK Department for 
International Development (DFID) have not been included.  
This methodology has three main limitations:  
1. It considerably underestimates DIF-H’s efficiency and cannot be used as an 
indication of per unit cost. In reality, the total DIF-H budget was used to 
cumulatively achieve all the results claimed. However, it is not possible to sum all the 
different results achieved and apportion individual costs to each result. Instead, a 
commonly used strategy is to divide the number of each type of result by the total 
cost of the program. This is repeatedly done for each type of result. The problem with 
this approach is that it treats each result as if it were the only result achieved, when in 
reality all the results were achieved from the same pot of money. Accordingly, the 
total budget is counted many times. Therefore the efficiency figures cannot be used 
                                               
15 Source: Compliance report, 2015. 
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to cost and budget for results, as this would imply a significant overestimation of the 
required budget. Rather the purpose is to provide a conceptual overview of efficiency.  
2. It does not include the real costs of the government’s investment in DIF-H. This 
is because the budget allocations for CIHR and IDRC are likely to be underestimates 
of the true costs incurred by these institutions. However, there is no actual costing of 
the resources spent. Therefore, we considered the full budget allocation of each 
agency for DIF-H activities as the nearest proxy.  
3. It does not include future results from current investments. For the purpose of 
this summative evaluation, and to respond to the Treasury Board criteria, the current 
efficiency ratio was estimated based on actual positive results achieved to date. 
Further results from current investments will be achieved in the future. Therefore, a 
more accurate estimation of efficiency requires an appraisal over a longer time 
period. 
5.3 Allocative efficiency 
Main messages: Allocative efficiency of DIF-H is acceptable, especially since more results 
from current investments will be achieved in the future. Findings of this evaluation provide 
benchmark data for future assessments of the DIF-H or similar programs.  
 
If DIF-H has saved 8,68916 lives, the cost of DIF-H saving one life is $18,487. The most 
efficient grand challenges in terms of cost per lives saved are the targeted challenges 
($7,589), then Stars ($56,343), then TTS ($228,421).  
Defining the value of saving a life has been the subject of intractable debate. There is today 
no internationally recognized standard to measure this outcome. Different organizations, 
including GCC, are working on this question.  
Regarding efficiency, however, international measures and benchmarks are available and, 
when used, make it possible to compare the efficiency cost of saving one life between 
different interventions or programs. Most economic appraisals use quality-adjusted life years 
(QALY) or disability-adjusted life years (DALY) as measures of health gains as a result of an 
intervention (Sassi, 2006). However, because GCC does not use these age-weighted 
measures, it makes it difficult to compare the allocative efficiency of DIF-H with other 
programs.  
For example, below we present a number of benchmarks with which to compare DIF-H’s 
cost of saving or improving a life. However, they are all based on the number of years of life 
that would be added by the intervention. By comparison, the metrics of lives saved and lives 
improved used by GCC only report the numbers of lives affected, not the number of years of 
life affected. For instance, and put crudely, if an intervention saved the life of a child with a 
high life expectancy, the number of QALYs would be high but the number of DIF-H lives 
saved would be one. Alternatively, if an intervention saved the life of an older person with a 
lower life expectancy, the number of QALYs would be lower, but the number of DIF-H lives 
saved would still be one. This makes any comparison very difficult, but generally one DIF-H 
life saved would normally be “worth” several QALYs. Therefore, GCC’s efficiency as 
                                               
16 Source: GCC Strategy Roadmap  
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measured through lives saved and lives improved will appear worse than if it was measured 
in QALY terms.  
Examples of international use of QALYs for estimation of an intervention’s 
efficiency   
The Public Health Agency of Canada (PHAC) has summarized the cost-effectiveness of a 
variety of prevention activities using QALYs (Public Health Agency of Canada, 2009): 
 
Source: Public Health Agency of Canada 
 
At first look, the cost of $18,487 per life saved by DIF-H would seem quite high in 
comparison to the interventions costed by PHAC. However, this is because PHAC costs 
are per year of life saved, not per life saved. Therefore the cost efficiency of a DIF-H life 
saved may actually be better, presuming each person saved would live longer than a year.  
In the UK, the National Institute for Clinical Excellence uses QALY to make its budgetary 
and prioritization decisions. The latter accepts a threshold incremental cost of C$40,000 
per QALY as being sufficiently cost-effective to justify UK National Health Service 
investment. Interventions with a marginal efficiency of between C$40,000 and C$60,000 
should be considered if there are strong additional reasons. Although these figures relate 
to implementation in HICs, they would still indicate that a DIF-H life saved is cost-efficient.  
Benchmarks are also available for LMICs. The World Bank (1993) derived a figure 
equivalent to C$197 per DALY to recommend a minimum care package of services that 
should be provided by LMICs, and this threshold was reiterated in 1996 in an effort to 
define research priorities. C$197 per DALY was specified as offering “attractive” cost-
effectiveness and C$33 per DALY as offering “highly attractive” cost-effectiveness for low-
income countries, with C$655 and C$131 per DALY, respectively, specified for middle-
income countries. On the basis of these assumptions, a DIF-H life saved is less cost-
efficient. However, once again this will depend on how many years of life were saved by 
each DIF-H life saved.  
 
To permit comparison and align with international benchmarks, GCC may like to consider 
using measures that better reflect age-weighted health gains (as with QALY and DALY), 
rather than just a global figure, such as lives saved. However, this will require additional data 
collection and detailed analyses, so may only be appropriate for periodic reviews, or a subset 
of projects/grand challenges. 
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5.4 Operational efficiency 
Main message: Operational efficiency of DIF-H and GCC is good, but there is some room 
for improvement. 
• Considering international benchmarks, DIF-H and GCC have been operationally 
efficient.  
• GCC is currently running too lean and could further increase efficiency through 
deepening investments into its own operations.  
• The DIF-H processes of launching RFPs, reviewing applications, and managing grants 
have been efficient for DIF-H, but may not be efficient for CIHR and IDRC. 
• DIF-H internal knowledge management has been inefficient.  
 
The investment in setting up DIF-H was initially high, but in the last two years operating costs 
have stabilized at around 10%. GCC estimates that its operating costs need to be 12% in 
order to be able to operate correctly. The evaluators agree that GCC is running too lean and 
suggest that GCC should increase its operational inputs to ensure that the quality and 
quantity of services required to deliver objectives are not compromised. In particular, it 
appears that GCC requires more staff, and particularly more specialized staff. In recognition 
of this, GCC has begun the process of recruiting additional staff and commissioning external 
specialists.  
A study in MoneySense (2013) gives an A+ rating for efficiency to organizations in the 
international development space that spend less than 15% of their funds on operations. 
Following this benchmark GCC would receive an A+. Table 9 shows GCC’s operational 
costs.  
 
















88% 66% 13% 4% 3% 3% 
Program 
support  
12% 24% 15% 5% 5% 7% 
Research 
program  
0% 10% 72% 91% 92% 90% 
Source: GCC 
 
‘General administration’ includes personnel, infrastructure, and business development for the 
administration and management staff (i.e., executive directors and some of the vice-
presidents). 
 
‘Program support’ includes personnel, infrastructure, and business development for the 
technical staff (i.e., some of the vice-presidents, portfolio managers, and all staff). 
 
‘Research program’ includes the grants and the research support activities (i.e., networking, 
monitoring, support to innovators, etc.). 
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DIF-H’s operational costs are higher because the set-up costs and the costs of IDRC and 
CIHR must be included. When these are added and averaged over the financial years, DIF-
H’s operating costs are approximately 15% or higher. This means that DIF-H would not 
receive an A+ for its operations, but it is still operationally efficient. DIF-H’s operating costs 
are shown in Table 10.  
 













GCC 2,610,087 4,628,210 5,634,120 6,803,961 - 19,676,378 
IDRC 900,000 900,000 900,000 900,000 900,000 4,500,000 
CIHR 180,000 180,000 180,000 180,000 180,000 900,000 
Total  1,080,000 5,708,210 6,714,120 7,883,961 1,080,000 25,076,378 
Source: GCC  
 
These data cover July 1, 2009 to March 31, 2011 and come from the IDRC record of actuals 
spent. The data are close to the GCC financial statements, but they do not match them 
exactly.  
 
The details of IDRC’s and CIHR’s allocated expenditure cannot be tracked for the full DIF-H 
allocation. The total budget was therefore evenly split throughout the program life. 
5.4.1 Efficiency of key DIF-H processes and activities 
The grantee selection system, based on GCC initial screening of RFPs and CIHR peer 
review, is functioning and efficient, although CIHR’s services are likely to have been 
undervalued. GCC has received 5,609 applications (2,960 for innovator-defined challenges 
and 2,649 for targeted challenges). CIHR prepared the peer-reviewed process, screened 
and scored more than 3,000 applications, and mobilized the highest level of Canadian and 
international researchers as peer reviewers.  
Based on the CIHR budget allocation for DIF-H, CIHR received $300 for each application 
reviewed and scored. By comparison, an evaluation of CIHR’s Open Operating Grant 
Program found that “the cost per application includes: $1,307 for direct and indirect 
administrative costs; [and] $1,812 in peer reviewer time; …Administrative costs are 
comparable with both NHMRC ($1,022) and the US National Institutes of Health ($1,893)” 
(CIHR, 2012a).  
On this basis, the system of contracting CIHR to provide scientific rigour to DIF-H is efficient 
for DIF-H: it would have been more expensive if an external non-public institution had been 
hired for the same purpose. However, the investment is unlikely to have been efficient for 
CIHR considering the difference between the funding provided by the Government of 
Canada and the costs cited by the CIHR evaluation. Furthermore, CIHR invested significant 
time, effort, and transaction costs to understanding and implementing a peer review system 
with integrated innovation as a key selection criterion.  
The project management system operated by GCC is functioning and efficient, although 
IDRC’s services also seem to have been undervalued. IDRC’s support has contributed to the 
development of a robust grant management system. This system enables low operational 
costs; it would have been more expensive to contract this support externally. However, the 
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investment may not have been efficient for IDRC, whose services and transaction costs in 
negotiating with the government seem to have been underestimated.  
Although the individual consortium members have demonstrated learning, knowledge 
transfer between the consortium members has been limited. This cost of reinventing the 
wheel has reduced DIF-H’s efficiency. The DIF-H consortium was built with institutions that 
each bring a unique and recognized excellence. The expertise of CIHR and IDRC were not 
always used by GCC when they were made available or offered. While this may have been 
appropriate in some circumstances, both the formative and summative evaluations consider 
that significant opportunities for knowledge transfer have been missed. Examples of a lack of 
knowledge transfer include:  
 
1. Measuring innovation. IDRC has more than 40 years of experience of monitoring and 
measuring the impact of research. Although IDRC provided GCC with support on 
monitoring and evaluation during DIF-H inception, GCC has been reluctant to accept 
further input from IDRC. This is in spite of the recommendations of the formative 
evaluation and the IDRC performance audit that found that GCC’s project-level 
monitoring needed strengthening. 
2. Local intelligence. IDRC has four regional offices (India, Uruguay, Kenya, Egypt), 
including countries with a large number of GCC innovators such as Kenya and India. 
This local Canadian intelligence has not been leveraged for DIF-H purposes.  
3. Integrated Knowledge Translation. CIHR has been a leader in the theory and practice 
of knowledge translation, in particular Integrated Knowledge Translation (CIHR, 
2012b17). Although the precise interpretation of Integrated Knowledge Translation differs 
from GCC’s Integrated Innovation, the content is sufficiently similar to have been of use 
to DIF-H. The evaluation found that the concept of integrated innovation now seems to 
be well understood by GCC and CIHR, and is established within the peer review criteria. 
However, the process of coming to this common understanding has been long and 
challenging. More carefully considering CIHR’s work on knowledge translation would 
have enabled the consortium to benefit from years of research, theory, and evidence-
based practice already available. 
5.5 Structure, governance and processes of DIF-H 
A final consideration for Core Issue 5 is how DIF-H’s structure, governance, and processes 
affect performance. DIF-H was not intended to be a “physical entity” with a board and a 
strategy but, rather, a consortium of three members with specific expertise to allow for the 
effective implementation of DIF-H and a mitigation of its risks. 
Evaluation of the consortium model requires consideration of the evolution of the DIF-H 
context. When DIF-H was created in 2008, the consortium model was a novel delivery 
mechanism for the Government of Canada. A formative evaluation was conducted at the 
program’s mid-life that provided evidence and lessons learned to support DIF-H 
performance. Now at the end of the first DIF-H funding cycle, seven years since inception, 
                                               
17 The target audience for this guide is CIHR applicants and reviewers, but the concepts are transferable to a 
broader audience. 
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this summative evaluation presents a retrospective assessment of the consortium’s 
performance and considerations for the future.  
Main message: Each DIF-H consortium member has performed its specified roles 
proficiently and as required. However, the governance of DIF-H needs further 
consideration. 
• There is no specific DIF-H leadership, strategy, nor established board and governance 
structure for DIF-H as an entity. Instead, GCC delivers these functions through its 
board and organizational processes. 
• While DIF-H is generally well run, there are risks associated with the program. The 
current governance mechanisms do not provide the government with a system to steer 
DIF-H activities. So the Government of Canada may be accountable for risks over 
which it has no control and, therefore, which it has limited ability to mitigate.  
• There has been limited ongoing scientific input throughout project life cycles and in 
relation to more recent management decisions. This means that opportunities to 
scientifically steer program developments have been missed and the scientific rigour 
and safety of project implementation cannot be guaranteed. 
5.5.1 DIF-H leadership and accountability 
There is no specific DIF-H leadership nor established board and governance structure for 
DIF-H as an entity. In the absence of DIF-H leadership, GCC’s board and Chief Executive 
Officer have provided strong leadership to the organization, which guided DIF-H’s 
implementation from the outset. Throughout the life of the program, GCC’s board has been 
strong, and has been committed to all operational aspects of GCC. The board of directors 
comprises 14 members, including the presidents of IDRC and CIHR who, through their board 
seats, have a fiduciary duty to GCC.  
The potential conflict of duty created by the dual roles for these directors, especially IDRC’s 
president, was raised in the formative evaluation. The summative evaluation found no 
evidence that the potential conflict of duties has caused any issues for GCC, and both IDRC 
and CIHR presidents have been recognized as excellent board members. Their commitment 
to GCC and strong support to the board has supported organizational strengthening and 
leadership.  
As mandated by the Treasury Board, IDRC is responsible for ensuring the accountability of 
DIF-H to the Government of Canada.18 Considering the oversight mechanism used by IDRC 
for its other grantees and federal programs, DIF-H has been afforded an appropriate 
accountability mechanism to assess the program ex post, as demonstrated by the following 
IDRC-led activities: 
1. Annual reporting to the Canadian government; 
2. Quarterly reporting from GCC;  
3. Formative and summative evaluations (2011, 2015), including a field visit to grantees 
in Peru as part of the summative evaluation;  
                                               
18 IDRC governs the flow of funds for DIF-H. It is also responsible for ensuring the accountability of DIF-H to the  
Treasury Board of Canada. 
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4. A performance audit (November 2014); and 
5. A field visit (Kenya, 2014). 
 
However, the evaluators found that the consortium’s decisions appear to have often been 
driven by power relationships both within and outside of the consortium. The evaluation 
concludes that IDRC’s position in steering strategic dialogue needs to be revised, as the 
institution does not currently have the relevant tools and mechanisms to do this. The 
evaluation team also notes that this model has hindered IDRC’s role in the provision of 
leadership in its areas of expertise, including evaluation, donor partnerships, and monitoring. 
By extension, the DIF-H governance model does not enable the Government of Canada to 
take on an ex ante role in setting DIF-H priorities or effectively steering strategic dialogue. 
This means that, although accountability is provided to the Canadian government, 
stewardship by the government is not possible.  
However, it is important to keep in mind that there is inevitably a trade-off between the 
government setting priorities for DIF-H and the need to protect GCC’s independence and 
responsiveness, which in turn enables the transfer of innovation-funding related risks from 
the government to GCC.   
5.5.2 DIF-H’s strategy  
The lack of a DIF-H strategy has reduced DIF-H’s ability to effectively and proactively take 
advantage of opportunities for collaboration among the consortium members and other 
governmental agencies and initiatives.  
With time, GCC has developed its own strategy, which has guided DIF-H implementation 
and resulted in a multitude of external partnerships. However, the strategic partnerships 
between DIF-H, its implementing arm, GCC, and other governmental agencies could have 
been enhanced with the guidance of a DIF-H strategy developed by the consortium; this 
would have represented consortium members going beyond their specific responsibilities to 
demonstrating an ownership of DIF-H.   
5.5.3 DIF-H delivery 
With respect to the duties assigned by the government, each DIF-H consortium member has 
performed its roles proficiently. However, the DIF-H model has not been able to address all 
the risks of its delivery. The main areas of concern are presented below. 
5.5.3.1 Scientific excellence and rigour  
The Government of Canada requires a guarantee that, through the DIF-H, it is funding 
excellent science. The Scientific Advisory Board helped ensure that DIF-H’s initial strategy 
was driven by expert thinking and evidence, and CIHR ensured that DIF-H-funded projects 
were scientifically sound. However, there is limited ongoing scientific input, which means that 
opportunities to scientifically steer program developments and ensure continuing rigour and 
safety of project implementation have been missed.  
In regard to the project proposals that CIHR was made responsible for reviewing, CIHR met 
its responsibilities to an excellent standard. However, CIHR was hindered in its peer review 
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by not having sole responsibility for the process. Conducting a peer review goes beyond 
reviewing the proposal; it starts from the outset by defining the selection criteria and finishes 
with the scoring and ranking of submissions. GCC was strongly involved in the definition of 
the selection criteria, and sometimes applied a first filter to the submissions before sending 
them to CIHR for peer review, occasionally pushing its own priorities when scoring and 
ranking submissions. It is understood that this was done in an effort to refine project 
selection so as to meet GCC needs; however, this interference resulted in significant 
transaction costs and risks for CIHR, and DIF-H’s reputation. Notably, there was a potential 
loss of transparency and scientific integrity of the peer review process. It is important to note 
that these initial tensions have now been resolved and that the peer review system is 
functioning at a satisfactory level.  
In addition to CIHR’s scientific input, GCC created the Scientific Advisory Board (as 
mandated by the Treasury Board submission) to provide two key functions: to identify and 
endorse the selection of grand challenges, and to provide scientific oversight and leadership 
to GCC. To this end, GCC successfully leveraged the investment of time and effort from an 
exceptional array of internationally respected scientists. The Scientific Advisory Board 
minutes from 2011 and 2012 demonstrate excellent engagement from the outset in key 
areas of GCC strategic development, including the selection of grand challenges, the scaling 
of innovation, and the move toward social financing.  
However, in 2013 a decision was taken for the Scientific Advisory Board to work through 
subcommittees to undertake detailed portfolio reviews of each grand challenge. Although 
GCC argues that this structural change supports greater efficiency, it is not clearly articulated 
in the minutes, and some Scientific Advisory Board members reported a lack of clarity about 
their roles and responsibilities with regard to the full board, compared with the 
subcommittees.  
Regardless of the relative merits of this decision for the portfolio review process, the 
Scientific Advisory Board no longer operated its leadership functions with the same level of 
engagement. Accordingly, opportunities were missed for engagement with the strategic 
direction of GCC and DIF-H (as opposed to the operational work of the individual grand 
challenges). For example, the full Scientific Advisory Board would have been well placed to 
support the validation of the methodology for outcome claims but it did not engage 
meaningfully in this area as it was not formally meeting during the critical time when this 
methodology was being developed. The formative evaluation of DIF-H also made 
observations regarding the lack of clarity of the Scientific Advisory Board’s role and issues of 
underperformance;19 the findings of this summative evaluation show that these concerns 
have still not been fully addressed.  
                                               
19 Other issues for improvement relating to the Scientific Advisory Board, contained in the formative evaluation, 
included:  
a) Lack of clarity about the role of the Scientific Advisory Board and involvement of the Scientific Advisory Board 
members;  
b) Lack of participation of the Scientific Advisory Board in setting the research priorities for GCC;  
c) Need for clear terms of reference and membership eligibility;  
d) Concerns about sufficient information being fed to the Scientific Advisory Board, particularly relating to the 
response to, and update of, the Scientific Advisory Board recommendations;  
e) Challenges because of the distance between members — suggestions include having a face-to-face meeting 
once a year and making use of video conferencing to improve connection of the Scientific Advisory Board 
members;  
f) Lack of engagement outside of board meetings — suggested that Scientific Advisory Board members would 
benefit from more frequent information, communication, and feedback. 
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However, GCC has recently strengthened ongoing scientific input into its targeted challenge 
projects through the use of specialist external support teams known as platforms. Projects 
that are transitioning to scale also undergo re-appraisal from a business as well as scientific 
perspective. These new mechanisms certainly represent important progress. However, at the 
time of the evaluation, business and scientific platforms were still finding their feet and Stars 
projects were not receiving ongoing oversight beyond reporting outcomes to GCC project 
officers. While this reporting function is important, it cannot guarantee the rigour and safety 
of Stars projects’ implementation. This is discussed further below.  
5.5.3.2 Identification and mitigation of risks 
GCC has developed a strong and efficient operational risk identification and mitigation 
system. A detailed risk matrix has been developed and a GCC vice-president is responsible 
for its updating and revisions, and mitigating risks when they arise. An escalation system is 
in place and key risks are reported quarterly to the GCC board. The evaluation team found 
that the system is active, has proven to be effective in different instances, and should be kept 
in the future.  
However, GCC-funded projects could pose potential risks to health systems in countries 
where they are implemented, and the current risk management system does not include a 
rigorous due diligence system for identifying project-related health systems risks. Such risks 
should be screened for and reviewed by a tailored due diligence process, to ensure that such 
projects are appropriate investments for the Canadian government. With few exceptions, 
GCC does not have in-country intelligence that can be used when assessing and monitoring 
its projects. The RFP selection criteria are the only guarantees that a project will, at the 
minimum, do no harm. While some reviewers have picked up on potentially harmful projects, 
this is not an explicit requirement. Examples that the evaluators consider to require ongoing 
due diligence include projects related to innovative health monitoring information systems 
that enable health staff to stop inputting data into national health management information 
systems; support to innovative health financing mechanisms, such as vouchers for health 
care; and provision of remote medical training for Caesarean sections.  
The Scientific Advisory Board does review the outcomes of the top performing projects, but it 
is afforded insufficient time and data to interrogate project activities more closely, and it 
cannot be expected to do this for all projects. Therefore a more systematic, yet efficient, 
mechanism for identifying and addressing project-related risks is needed.  
5.5.3.3 Operations 
When the Treasury Board created DIF-H and GCC as its implementation arm, the 
Government of Canada considered the operational risks of this new program to be significant 
and established the DIF-H consortium as a mitigation strategy. 
As per the memorandum of understanding, IDRC was made responsible for helping GCC to 
get off the ground, designing all of its internal systems and the challenge fund mechanism 
and procedures. Accordingly, IDRC ranked GCC as a high-risk grantee. The support 
provided by IDRC was valued by all consortium members and was recognized as a key 
enabler of GCC becoming an efficient challenge fund and grant manager. GCC is now 
regarded by IDRC to have performed well as a grantee, with relevant robust systems and 
procedures in place. This was confirmed in the last GCC external audit conducted by Ernst 
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and Young, where no comments were made otherwise. Owing to these successes, it may 
now be time to review the requirement that IDRC provide technical support to GCC. 
5.5.3.4 Public accountability  
DIF-H has no external communication or branding. GCC has filled this gap and invested in 
communication that ensures recognition is given to the Canadian government. While this 
brands the Government of Canada by associating its name with GCC activities, this poses 
reputational risks for the government. 
 
GCC brands its actions and activities as Government of Canada actions and activities, as 
mandated in the Treasury Board submission. The evaluators can confirm that it is widely 
known that GCC is funded through Canadian taxpayer dollars. However, the Government of 
Canada has no control or oversight over GCC’s strategy, only an ex post audit and 
evaluation role implemented through IDRC. As mentioned previously, this does not provide 
an adequate leadership framework for IDRC or the Government of Canada. 
 
Additionally, this approach makes the Government of Canada appear to be the sole entity 
responsible for GCC’s financial sustainability. With this branding approach, if the government 
were to discontinue funding DIF-H, and this resulted in the termination of GCC operations, 





Development Innovation Fund – Health; Summative Evaluation Report 
© Oxford Policy Management 49 
 
Conclusions and recommendations 
The evaluation evidence presented in this report supports the following conclusions and 
recommendations. 
Overall conclusion: The Government of Canada’s investment in DIF-H provides value for 
money. 
Relevance conclusion 
The Development Innovation Fund – Health is a highly relevant investment for the Government of 
Canada. 
DIF-H addresses demonstrable needs for Canadians and the international community. These needs 
include the continuing requirement for financing to support innovations in global health, resolving 
barriers to global health and safety, and promoting development and equity in LMICs. The alignment 
of DIF-H with several of the contemporary Sustainable Development Goals highlights this. Innovation 
is also recognized as a relevant and cost-effective way to address global health challenges, and 
investment in DIF-H has contributed to positioning Canada at the forefront of international efforts to 
rethink development modalities. DIF-H also provides Canadian innovators with increased opportunities 
to engage with LMIC innovators and research institutions. Furthermore, the Canadian public values 
this national support to international development and global health, as it recognizes the potential 
dangers of global health risks. 
DIF-H is well aligned with the Government of Canada’s thematic priorities in global health, 
development, and innovation. Within global health, DIF-H activities closely align with priorities for 
Canadian ODA and, particularly, maternal, neonatal, and child health. Regarding development and 
innovation, the DIF-H funding modality has strong complementarity with other governmental agencies’ 
innovation strategies, both domestic and international. Although there is only partial geographical 
alignment with ODA focus countries, positive impacts arising from DIF-H can be applied to these 
countries in due course.   
DIF-H also offers a valuable contribution to Canada’s diplomatic agenda, and GCC has established an 
impressive set of formal and informal international partnerships and networks. Nevertheless, DIF-H 
would benefit from a clearer strategic vision for coordinating with, and working alongside, other 
governmental development initiatives.  
Although a thorough interrogation of alternative mechanisms for DIF-H was not conducted during an 
inception period, the consortium mechanism for DIF-H was relevant for the management of an 
innovation fund and as a funding delivery vehicle. The decision to create GCC as a new organization 
was appropriate and remains valid at the present time. 
Performance conclusion 
Reasonable expectations of outcomes have been achieved or exceeded. These outcomes have been 
produced with appropriate regard to economy, acceptable levels of allocative efficiency, and good 
levels of operational efficiency. While the structure, governance, and processes of DIF-H were largely 
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effective, there remain opportunities for improvement, and the governance of DIF-H requires further 
consideration in light of program developments.  
Although it is not possible to assign an exact figure due to methodological and data limitations, the 
projects funded through DIF-H have resulted in relatively high numbers of lives saved; lives improved; 
beneficiary access to health products and services; and positive impacts on health policies, training 
practices, and health systems in LMICs. Importantly, more results can be expected in the future as 
current investments mature and reap further health gains.  
This has been achieved through the development of a large number of innovative prototypes and 
service delivery models, a good proportion of which are being scaled up. These projects have also 
resulted in a commendable number of publications, patents, and patents pending. DIF-H grants have 
also contributed to increased jobs and funding to address global health challenges through innovation, 
especially given GCC’s effective leveraging of funds.  
In several cases, the consortium members went above and beyond the activities expected of them. 
Most notably, GCCs efforts at promoting grantee networking and capacity building, and developing 
partnerships with other international governments and organizations, should be applauded. The 
requirement that DIF-H should increase knowledge and awareness of a positive international Canada 
brand has been met.   
Overall, the principles underlying the DIF-H theory of change appear to be well founded. This has 
arguably contributed to the successful achievement of results observed and is testament to the early 
and ongoing efforts of GCC and IDRC in developing the program theory.  
Despite these achievements, lack of transparency when calculating results and inconsistencies in the 
reporting of outcomes damages the credibility of claims by allowing skepticism of genuine results. To 
remedy this, the evaluators recommend that GCC undertake a comprehensive review of its monitoring 
and reporting arrangements. Although it is acceptable to only report the results from top performing 
projects for promotional purposes, this should not preclude systematic monitoring of all projects and 
the provision of sufficient information for external parties to critically assess claims. These basic 
principles of rigour will serve to build trust in the results achieved and to facilitate knowledge sharing 
that will benefit the wider innovation for development community.  
Cost–utility analysis reveals that DIF-H has been economical, allocative efficiency is acceptable, and 
operational efficiency is good. If predicted future results from current investments could be included, 
efficiency would be even better.  
However, the evaluation team concludes that GCC is currently running too lean and could further 
increase efficiency through deepening investments into its own operations. Particular areas of 
opportunity include monitoring and evaluation and hiring specialist staff. Furthermore, some of the 
DIF-H economies may not actually be net savings for the Government of Canada, because the 
services provided by CIHR and IDRC appear to have been undervalued. The exact funding shortfall 
incurred by these organizations due to insufficient government funding allocation is unknown because 
resource outputs assigned to DIF-H were not tracked.  
At this stage, it is not possible to assess if DIF-H is more or less efficient than other government 
investments in global health because more time is required for the final outcomes of DIF-H 
investments to become apparent; GCC uses different metrics from international norms of efficiency, 
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which makes efficiency comparisons difficult; and no benchmarks have been established for GCC 
metrics (e.g., lives saved or lives improved). While the summative evaluation provides benchmark 
data for future assessments of the DIF-H or similar programs, using efficiency measures that better 
reflect age-weighted health gains (as with QALY and DALY), rather than just a global figure, would 
enable international comparisons.  
DIF-H’s structure, governance, and processes have, on the whole, served the program well. All 
consortium members have performed their roles and responsibilities proficiently, added value and 
unique expertise, and contributed to the achievement of results. The contribution of internal and 
external committees, institutions, and stakeholders has leveraged critical support and brought in the 
necessary expertise, as required.  
However, there has been limited ongoing scientific input throughout project life cycles and in relation 
to more recent management decisions. This means that opportunities to scientifically steer program 
developments have been missed and the scientific rigour and safety of project implementation cannot 
be guaranteed.  
Furthermore, the choice to not establish a specific entity to operate DIF-H, and defer all leadership, 
strategy, and operational decisions to the GCC board opens the Government of Canada up to risks 
that are beyond its control to mitigate. Importantly this structural set-up reduces IDRC’s mechanisms 
for strategic direction, even though it is the agent that is accountable to the government.  
Future considerations 
Moving forward, there are multiple options open to the Government of Canada, each having certain 
advantages and disadvantages. 
If the government is interested in continuing to fund global health innovations, this second phase of 
support must address the following issues:  
1. How much the government wants to continue supporting challenge funds for innovation, and if 
the fund should continue to be solely allocated to the health sector or be expanded and/or 
focused on other sectors; 
2. How much the government wants to keep the same delivery modality, in which case the 
current consortium modality needs to be revisited in light of the findings of this evaluation and 
the maturity of a now well-established GCC. 
If further investment is allocated to DIF-H in its current form, a key consideration will be determining 
the extent to which the Government of Canada wishes to steer the strategic direction of these funds. 
As GCC becomes increasingly externally financed and its accountabilities diversify, the Canadian 
government’s stewardship influence will be weakened. However, increasing government control risks 
undermining the purposes for which GCC was created (independence, flexibility, and responsiveness) 
and could even have negative impacts on GCC and grantee performance.  
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Recommendations 
Regardless of the future form that DIF-H takes, the following recommendations should be considered 
to improve program relevance and performance.  
Recommendation 1: Better strategy. DIF-H should develop an applied and dynamic, consortium-
level strategy for outlining coordination with Canadian aid and other governmental initiatives in global 
health and development. A DIF-H strategy should also formalize expected visibility arrangements and 
improve internal knowledge transfer and cooperation between consortium members. The same is 
recommended of any DIF endeavour into other fields of innovation (e.g., environment, agriculture, 
education, etc.). 
Recommendation 2: Strengthen scientific oversight. Although CIHR peer review ensures that 
funded projects are scientifically rigorous at their earliest stages, there are few mechanisms to ensure 
that scientific standards of projects are maintained post-implementation. Mechanisms should be put in 
place to guarantee the scientific integrity of funded projects throughout their life cycle. While the 
Scientific Advisory Board does review the outcomes of the top performing projects, it is afforded 
insufficient time and data, and it lacks sufficient resources and mandate to do this for all projects. 
Therefore a more systematic, but efficient, mechanism is needed. GCC’s formation of specialist 
platforms to support the targeted challenge and Transition to Scale grand challenges are a step in the 
right direction, but GCC should pay greater attention to the Stars projects. 
The decision that the Scientific Advisory Board should work through subcommittees has resulted in 
reduced scientific leadership and input. Accordingly, opportunities were missed for engagement with 
the strategic direction of GCC and DIF-H (as opposed to the operational work of the individual grand 
challenges). DIF-H must consider these implications and work to ensure that management decisions 
continue to be supported by expert scientific thinking 
Recommendation 3: Optimize metrics. The results indicators used by GCC require further 
refinement to make them more precise and objective. Adopting international measures of efficacy that 
better reflect age-weighted health gains would also enable international comparisons of efficiency. The 
evaluators appreciate that there are advantages and limitations of different measurement 
methodologies, but the use of common metrics and benchmarks could help facilitate reporting, and 
form the basis for target setting.  
Recommendation 4: More rigorous monitoring and reporting. GCC should undertake a 
comprehensive review of its monitoring and reporting arrangements. These need to be more 
systematic, transparent, and consistent, so as to balance the externally facing promotional approach 
with the need for scientific rigour. To ensure credibility, there should be an audit trail connecting raw 
data to final results claims. 
Recommendation 5: Seize efficiency opportunities. GCC is an efficient organization. However, 
further operational investment would increase efficiency to a greater extent and avoid the risk of 
underperformance. Although this represents a trade-off with cost minimization, investment in areas 
such as more comprehensive monitoring and additional specialist staff could improve results and 
reporting that will balance the allocative efficiency ratio of inputs to outcomes—in simpler terms, doing 
more with more. 
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DIF-H should review the funds allocated to IDRC and CIHR to ensure that they cover the actual costs 
incurred in providing services to DIF-H. This allocation should be based on an estimation of previous 
resource use. Future resources provided to DIF-H should be tracked to prevent under- or over-
allocations.  
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1) Purpose of the Evaluation Management Plan 
 
This document provides over-arching principles for the International Development Research 
Centre’s (IDRC) management of the 2014-2015 summative evaluation of the Development 
Innovation Fund – Health (DIF-H). The parameters and guidance provided herein shall be applied 
by the IDRC, Grand Challenges Canada (GCC), and the Canadian Institutes of Health Research 
(CIHR) with a view to providing an independent, accountability-focused assessment of the DIF-H.  
 
Responsibility for the management of the evaluation of the DIF-H was directed to the IDRC by the 
Treasury Board Secretariat of Canada (TBS) through Memorandum to Cabinet.     
 
It is noted that GCC will convene an International Peer Review exercise along similar timelines as 
the summative evaluation. This document does not preclude the management approach GCC 
applies to that independent process.  
 
2) Summative Evaluation of The Development Innovation Fund – Health 
 
The Government of Canada established the Development Innovation Fund (DIF) in 2008. As 
announced in that year’s federal budget, the Fund aims to 
 
‘… support the best minds in the world as they search for breakthroughs in global health and other 
areas that have the potential to bring about enduring changes in the lives of millions of people in 
poor countries.’ 
 
A three-party consortium implements the DIF-H. It includes IDRC, CIHR, and GCC. Further details 
on the DIF-H are available on the websites of each implementing agency. 
 
The Memorandum to Cabinet establishing the DIF-H called for a return to Cabinet following a 
formative evaluation of the DIF in year 3 and prior to funding being renewed beyond the initial 
phase. The formative evaluation was completed in the fall of 2013; however, it did not provide 
enough information for Ministers to base a renewal decision. The MC also called for a return to 
Cabinet following the completion of a summative evaluation ‘to assess research results’.   
 
3) Guiding principles of the evaluation 
 
The evaluation of the DIF-H shall be designed, conducted, and managed with adherence to the 
following guiding principles: 
 
Credibility of the process and results, through adherence to the Guidelines of Ethical Conduct of 
CES  
 
Independence of the evaluation team  
 
Transparency in content and process 
 
Fairness towards all relevant stakeholders 
 
Efficiency in the use of resources 
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The assurance of independent inquiry is a theme of evaluation governance. To support this, an 
external and independent evaluator(s) will be commissioned to conduct the evaluation of the DIF-
H. An external assessment is an accepted best practice when seeking to mitigate the risk of 
internal interference and can be a method of increasing the credibility of the evaluation findings. 
 
Although the IDRC has been specifically directed to manage the evaluation function of the DIF-H, 
and therefore any external evaluator(s) hired to conduct related activities, an oversight structure 
will be initiated to support the IDRC in its evaluation management role. This oversight structure is 
designed to uphold an independent and transparent process. The structure will be comprised of 
two discrete committees:   
   
1 - The DIF-H Evaluation Committee is charged with regular discussion of issues pertinent to the 
evaluation. It is chaired by the Evaluation Office of the IDRC and is composed of senior level 
representatives of each consortium member - IDRC, GCC, CIHR. The DIF-H Evaluation committee 
will meet at a minimum of four critical check-in points. These are: 
 
1) At evaluation initiation, to discuss the management approach and committee roles and 
responsibilities – notional date in January 2014; 
2) At the evaluation planning stage, to discuss the evaluation approach presented by the 
independent evaluator(s) – notional date in March 2015;  
3) At a preliminary findings stage, to respond first hand to evaluation findings prior to 
report publication – notional date in July 2015;  
4) At evaluation conclusion, to contribute to the management response, to be written by 
IDRC, responding to the recommendations of the evaluation – notional date, 
September/October 2015.   
 
(Following nominations by the Head of each consortium member, this Committee is comprised of: 
Jocelyn Mackie, Vice-President, GCC; David Peckham, Director General, CIHR; and Robert 
McLean, Senior Program Specialist, IDRC.  The Chair is Lisa Woodward, Head of Evaluation, 
IDRC.) 
 
2 - The DIF-H Evaluation External Oversight Committee is charged with making decisions by 
consensus on critical evaluation issues. It is comprised of three external subject area experts who 
are deemed to be independent of any consortium member, and in addition, it may include one ex-
officio representative of the Government of Canada with significant expertise in Evaluation. The 
committee is convened by the Evaluation Office of the IDRC. The committee shall convene at a 
minimum of three critical decision points. These are: 
 
1) To select the evaluator(s). By reviewing applications and applying their expert 
judgement against the criteria of evaluator(s) experience as well as feasibility and rigour of 
approach.   
2) To approve the evaluation design report. Based on the evaluator(s)’ proposed design 
and discussion by the DIF-H Evaluation Committee, the committee will draw upon their 
expertise in approving the design of the evaluation. 
3) To approve the final evaluation report. Upon conclusion of the evaluation the final 
report will require approval of the External Oversight Committee. The committee will draw 
upon their expertise to apply the Guiding Principles of the Evaluation in approving the final 
evaluation report.     
 
(Following nominations by the Head of each consortium member, a collaborative cross-consortium 
ruling on independence of each candidate, and a signed statement of independence by each 
nominee, this Committee is comprised of: Katie Wehr, Program Officer, Robert Wood Johnson 
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Foundation (GCC nominee); Kathryn Graham, Executive Director Performance Management and 
Evaluation, Alberta Innovates Health Solutions (CIHR nominee); and François Dumaine, Partner, 




A second theme of evaluation governance is the assurance of rigorous inquiry. To support this 
theme while meeting the needs of evaluation users, evaluation questions will be created drawing 
upon guidance provided by the TBS Policy on Evaluation (2009) core issues as well as the input of 
DIF-H consortium members. The selected evaluator(s) shall apply a contextually appropriate and 
scientifically advanced methodology to answer evaluation questions. The creation of clear, 
accountability-oriented evaluation questions and the application of a robust methodology will 
bolster the accuracy and credibility of evaluation findings, and therefore, the pertinence of 
associated recommendations.  
 
4) Evaluation schedule 
 
The evaluation shall be conducted along the following schedule: 
 
• Convening of the DIF-H Evaluation Committee and DIF-H External Oversight Committees – 
December 2014 
• Selection of evaluator(s) – January 2015 
• Evaluation Design Plan – March 2015 
• Preliminary findings presentation – July 2015 
• Final evaluation report – September 2015 
• Management response – October 2015 
 
5) Evaluation resources 
 
Given the requirement for external assessment, the budget shall be managed by the IDRC and 
dispersed to the selected evaluator(s) on a pay for deliverable basis.  
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questions to be 
answered 





























need, and has it 
evolved to meet 
emergent needs? 
The degree of agreement regarding 
the view that mobilizing and enabling 
Canadian and international innovators 
to develop innovative solutions to 
critical global health challenges, and 
facilitating the implementation and 
commercialization of these solutions, 
can improve global health outcomes 
in LMICs 
Published and grey literature from respected 
international organizations and documents 
provided by GCC 
Literature review 




Board of directors 
Key informant 
interviews (KIIs) 
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
CIHR senior management involved with DIF-H KIIs 
Global donors operating in similar sectors KIIs 
Other grand challenge family members KIIs 
Organizations operating in health innovation 
sectors 
KIIs 
Government of Canada KIIs 
Other subject matter experts KIIs 
The degree of alignment between the 
global health issues addressed by 
DIF-H and international priorities and 
expert thinking on global health needs 
Published and grey literature from respected 
international organizations and documents 
provided by GCC 
Literature review 




Board of directors KIIs 
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
Global donors operating in similar sectors KIIs 
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Other grand challenge family members KIIs 
Government of Canada KIIs 
Other subject matter experts KIIs 
The degree of agreement regarding 
the view that DIF-H’s approaches are 
appropriate for enabling and 
mobilizing Canadian and Southern 
scientists to develop innovations, and 
to facilitate the implementation and 
commercialization of the innovations, 
and that DIF-H has evolved to meet 
emergent needs 
Published and grey literature from respected 
international organizations and documents 
provided by GCC 
Literature review 




GCC Scientific Advisory Board KIIs  
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
CIHR senior management involved with DIF-H KIIs 
Other grand challenge family members KIIs 
Organizations operating in health innovation 
sectors 
KIIs 
Canadian and international grant recipients, 
local stakeholders in and beneficiaries of GCC 
projects, local grand challenge family 
implementers 









The degree of agreement regarding 
the view that mobilizing and enabling 
Canadian innovators is important for 
Canadians and meets their needs 
 
Published and grey literature on relevant 
domestic issues, including governmental 
documents and resources, and documents 
provided by GCC 
Literature review 




GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
CIHR senior management involved with DIF-H KIIs 
Government of Canada KIIs 
Canadian grant recipients 
 
Surveys and case 
studies 
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The degree of alignment between 
DIF-H’s strategic objectives and 
government’s priorities, focusing on 
objectives relating to: overcoming 
global health challenges; developing, 
implementing and commercializing 
health innovations; enabling and 
mobilizing Canadian and Southern 
scientists; and establishing Canada as 
a key player in global health 
Governmental documents, and resources and 
documents provided by GCC 
Literature review 
Board of directors KIIs  
IDRC senior management involved with DIF-H KIIs 
GCC senior management KIIs 
Relevant IDRC departmental directors FGDs  
Government of Canada KIIs 







and ODA strategic 
outcomes? 
The degree of agreement regarding 
the view that DIF-H and GCC 
strategic objectives complement and 
reinforce Canadian international aid 
and ODA commitments, focusing on 
objectives relating to: overcoming 
global health challenges; developing, 
implementing and commercializing 
health innovations; enabling and 
mobilizing Canadian and southern 
scientists; establishing Canada as a 
key player in global health; engaging 
strategic partners (capital investment 
for global health and other grand 
challenge partners); and exploring 
ways to finance health innovation  
Governmental documents, and resources and 
documents provided by GCC 
Literature review 
Board of directors KIIs 
IDRC senior management involved with DIF-H KIIs 
GCC senior management KIIs 
































To what extent is 
DIF-H aligned with 
federal roles and 
responsibilities? 




federal roles and 
responsibilities? 
The degree of alignment between 
DIF-H and federal roles and 
responsibilities; the degree of 
agreement regarding the view that 
DIF-H is an appropriate modality for 
supporting these federal roles and 
responsibilities 
Governmental documents and documents 
provided by GCC 
Literature review 
Board of directors KIIs  
IDRC senior management involved with DIF-H KIIs 
GCC senior management KIIs 
Government of Canada KIIs 
3.2 
How is DIF-H 
aligned with other 
The degree of alignment between 
DIF-H’s strategic objectives and 
Governmental documents and documents 
provided by GCC 
Literature review 
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provincial roles and 
responsibilities, 
and does it help 
the Government of 
Canada to deliver 
these mandates? 
provincial roles and responsibilities, 
and the degree of agreement 
regarding the view that DIF-H helps 
the Government to deliver on these 
mandates 
IDRC senior management involved with DIF-H KIIs 

































milestones set and 
adapted as 
necessary?  
A clear list of unambiguous 
performance targets, expected 
outcomes and milestones set at the 
outset of the initiative; targets, 
expected outcomes and milestones 
are agreed upon by all parties and are 
seen as appropriate, feasible and 
useful; targets, outcomes and 
milestones are adjusted in alignment 
with program development; the 
adjustment of targets, expected 
outcomes and milestones is seen as 
appropriate and adding value 
DIF-H (including GCC, IDRC and CIHR) 
program documents 
Document review 
Board of directors KIIs  
Scientific Advisory Board KIIs 
Formative evaluation team lead KIIs 
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
Canadian and international grant recipients, 
and declined grant recipients 
 
Surveys and case 
studies 
4.2 
How many grand 
challenges and 
competitions were 
launched and did 
this process result 
in applications that 
met DIF-H 
requirements and 
were aligned with 
DIF-H objectives? 
To what extent was 
this process 
transparent, clear, 
fair and inclusive? 
The number of grand challenges 
launched; the number of calls and 
RFPs per grand challenge; the 
number of applications per RFP; the 
number of, and diversity of, applicants 
from HICs, LMICs, and partnerships; 
the number of applications from 
applicants with limited capacity; the 
quality of applications; the 
transparency, clarity, fairness and 
inclusiveness of RFPs; the extent to 
which these outputs met targets and 
attracted the desired profile of 
applicants and project proposals 
RFP documents Document review 
CIHR review documentation and reports Document review 
GCC review documentation and reports Document review 
GCC and CIHR monitoring/reporting data Data review 
CIHR individuals involved in review KIIs 
GCC senior management KIIs 
Canadian and international grant recipients, 
and declined grant recipients 
Surveys and case 
studies 
4.3 
How many grants 
were given and did 
this process result 
in grantees and 
The number of grants given for each 
RFP; the value of grants; the number 
of grants awarded compared to 
applications for each RFP; the 
GCC portfolio documents and database 
Document and 
data review 
CIHR review documentation and reports Document review 
GCC review documentation and reports Document review 
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projects that met 
DIF-H 
requirements and 
were aligned with 
DIF-H’s objectives? 
To what extent was 
this process 
transparent, clear, 
fair and inclusive? 
number of grantees funded for each 
grand challenge; the number of, and 
diversity of, grantees from HICs, 
LMICs, and partnerships; the number 
of grantees with limited capacity; the 
transparency, clarity, fairness and 
inclusiveness of the decision-making 
process; the degree of agreement in 
the decision-making process; the level 
of feedback provided to applicants; 
the extent to which the funded 
projects met targets and attracted the 
desired profile of grantees and 
projects 
GCC and CIHR monitoring/reporting data Data review 
CIHR individuals involved in review KIIs 
Scientific Advisory Board KIIs 
GCC senior management KIIs 
Canadian and international grant recipients 
 





was created, and 





terms of supporting 
the achievement of 
its stated 
objectives? 
The percentage and number of 
projects leading to proof-of-concept 
knowledge; the number of 
publications/presentations/citations 
arising from proof-of-concept 
knowledge; the extent to which the 
proof-of-concept knowledge met 
targets and created the required 
portfolio of knowledge products for 
each grand challenge 
GCC portfolio documents and database 
Document and 
data review 
GCC monitoring/reporting data Data review 
Scientific Advisory Board KIIs  
Investment Committee KIIs  
GCC senior management KIIs 
Canadian and international grant recipients, 
local stakeholders and beneficiaries of GCC 
projects, local grand challenge family 
implementers 
Surveys and case 
studies 
4.5 





do these products, 
services and 
models meet DIF-
H’s requirements in 
terms of supporting 
the achievement of 
stated objectives? 
The number of proof-of-concept 
knowledge products translated into 
implementable products/services per 
RFP and grand challenge; the 
percentage of projects that led to 
implementable products/services; the 
number of patents or intellectual 
property items filed/secured; new 
models for private investment 
developed; the number of public and 
private entities engaged and the 
amount of funding leveraged; grand 
GCC portfolio documents and database 
Document and 
data review 
GCC monitoring/reporting data Data review 
Scientific Advisory Board KIIs 
Investment Committee KIIs  
Canadian and international grant recipients, 
local stakeholders and beneficiaries of GCC 
projects, local grand challenge family 
implementers 
Surveys and case 
studies 
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challenge-specific organizations / 
communities/ partnerships created or 
supported; the extent to which these 
products, services, models and 
financing met targets and created the 
required portfolio of business and 






adopted and used, 




adoption and use? 
Do these outcomes 
support DIF-H’s 
objectives? 
The number of innovations scaled per 
RFP and grand challenge; the 
percentage of innovations that have 
been scaled; the amount of debate 
regarding, and the testing, adoption 
and usage of, innovations; the extent 
to which these scaled products, 
services and models met targets and 
supported DIF-H’s objectives 
GCC portfolio documents and database 
Document and 
data review 
GCC monitoring/reporting data Data review 
GCC program officers and portfolio managers FGDs 
Scientific Advisory Board KIIs 
Investment Committee KIIs  
Canadian and international grant recipients, 
local stakeholders and beneficiaries of GCC 
projects, local grand challenge family 
implementers 







achieved and what 
potential is there 
for future gains, in 
terms of lives 
saved and 
improved in 
LMICs? Do these 
outcomes support 
DIF-H’s objectives? 
The number of lives saved and 
improved in LMICs per grand 
challenge; the number of lives saved 
and improved for each successfully 
implemented and scaled innovation; 
the potential for further gains in lives 
saved and improved from currently 
implemented innovations and 
innovations in the pipeline; the 
expected timeline to impact for 
potential future gains; the lives saved 
and improved disaggregated by 
projected versus observable gains; 
the validity of projected gains; the 
extent to which these outcomes met 
targets and supported DIF-H’s 
objectives 
GCC portfolio documents and database 
Document and 
data review 
GCC monitoring/reporting data Data review 
IDRC individuals involved in monitoring GCC 
performance 
KIIs 




Scientific Advisory Board KIIs 
GCC senior management KIIs 
Canadian and international grant recipients, 
local stakeholders and beneficiaries of GCC 
projects, local grand challenge family 
implementers 
Surveys and case 
studies 
Global donors in similar sectors;  KIIs 
Grand challenge family members KII 
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solutions to critical 
health bottlenecks 
in LMICs? 
Increase in DIF-H grantees’ capacity 
to address global health challenges, 
as indicated by: their improved 
knowledge and ability to undertake 
health innovation work and secure 
funding; an increase in the number of 
their publications; their generation of 
new knowledge and products; their 
career progression; and their access 
to supportive partnerships and 
collaboration. Also, the number of 
projects funded that involved 
collaboration and partnership; the 
number of grand challenge-targeted 
models and networks created and 
supported; the perceived increase in 
opportunities to address global health 
challenges through innovation 
GCC portfolio documents and database 
Document and 
data review 
GCC monitoring/reporting data Data review 








Scientific Advisory Board KIIs  
Canadian and international grant recipients, 
and declined grant recipients, local 
stakeholders and beneficiaries of GCC 
projects, local grand challenge family 
implementers 
Surveys and case 
studies 
Subject matter experts: global donors in similar 
sectors; grand challenge family members; 




Has DIF-H helped 
brand Canada as a 





The degree of agreement regarding 
the view that DIF-H has created a 
positive brand for Canada as a 
thought leader in innovation and 
financing for global health; the number 
of countries adopting the GCC 
approach 
Published and social media material on DIF-H 
and GCC, and documents provided by GCC 
Literature review 




Board of directors KIIs 
GCC senior management KIIs 
Global donors operating in similar sectors KIIs 
Other grand challenge family members KIIs 
Organizations operating in health innovation 
sectors 
KIIs 
Government of Canada KIIs 
Canadian and international grant recipients, 
declined grant recipients, local stakeholders 
and beneficiaries of GCC projects, local grand 
challenge family implementers 
Surveys and case 
studies 
Other subject matter experts KIIs 
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current and future 
outcomes?  
Overall financial inputs to DIF-H in 
relation to currently observed 
outcomes: financial cost per 
innovation developed; financial cost 
per innovation scaled and made 
available; and financial cost per life 
saved and improved, as claimed by 
GCC. Also, the financial inputs to 
projects that have claimed health, 
economic and social benefits; 
outcome targets are clearly defined; 
clear mechanisms are in place to 
monitor inputs, outputs and outcomes; 
risk mitigation strategies are in place; 
evidence that actions have been 
undertaken to reduce resource 
consumption and maximize 
outcomes—in particular, appropriate 
management and support for funded 
projects; evidence of program learning 
and action—in particular, identification 
and appropriate termination of failing 
projects 
DIF-H administrative and financial data Data review 




Board of directors KIIs  
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
IDRC personnel involved with monitoring KIIs 
Canadian and international grant recipients, 
and local stakeholders and beneficiaries of 
GCC projects  











Overall and GCC proportion of funds 
spent on administration and 
operations compared to grants given; 
quality, quantity, timeliness and 
appropriateness of key targets; 
funding dispersed to GCC; grand 
challenges identified and competitions 
launched; peer review of applications; 
grants given; program monitoring and 
learning. Evidence that actions have 
been undertaken to improve 
operational efficiency 
Literature on the operational efficiency of other 
programs 
Literature and data 
review 
DIF-H administrative and financial data Data review 




GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
IDRC personnel involved with monitoring KIIs 




What attempts at 
economy have 
been made by DIF-
Evidence that management attempted 
to minimize procurement costs; 
evidence that mechanisms to monitor 
Literature on the economy of other programs 
Literature and data 
review 
DIF-H administrative and financial data Data review 
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H and do these 
actions appear to 
have resulted in an 
acceptable level of 
economy? 
and reduce inputs were put in place; 
evidence that all acquired inputs were 
utilized, absorbed and needed; 
evidence that sufficient quality and 
quantity of inputs were acquired to 
meet DIF-H’s needs and that lack of 
resources did not compromise DIF-
H’s performance 




GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 














models result in 
better or worse 
performance? 
Roles, responsibilities and 
accountabilities are clearly defined 
and implemented as planned; 
program adaptations are clearly 
defined and agreed by all parties; 
consortium member activities are 
carried out effectively, 
synchronistically and synergistically; 
evidence of good communication and 
cooperation; timely and effective 
dispute resolution; evidence that 
information flows between partners in 
a timely and appropriate way. Also, 
consortium partners add collective 
value to DIF-H by: providing inputs 
that individual members could not 
contribute to the same degree alone, 
permitting more rapid start-up time, 
minimizing risk, and improving 
effectiveness, efficiency and 
economy. In addition, DIF-H roles do 
not compromise the ability of 
individual partners to function 
effectively; alternative models for DIF-
H are explored and appropriately 
rejected; and the degree of agreement 
regarding the view that explored or 
hypothetical alternative models would 
not result in better performance 
DIF-H and consortium member documents  
Literature and data 
review 




Board of directors KIIs  
GCC senior management KIIs 
IDRC senior management involved with DIF-H KIIs 
CIHR senior management involved with DIF-H KIIs 
Government of Canada KIIs 
GCC program officers and portfolio managers FGDs 
Relevant IDRC departmental directors FGDs  
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C. Information on data sources used to inform this evaluation  
Data sources used for the evaluation of Core Issues 1, 2, 3 and 5 
The following data sources were used to inform the findings for the relevance section (Core 
Issues 1, 2 and 3), and the efficiency section (Core Issue 5) of the evaluation. These data 
sources were also used to provide context to the results achieved section (Core Issue 4), 
and to cross-check findings, but they were not used to determine the results that DIF-H 
achieved.  
DIF-H document portfolio 
GCC provided an extensive portfolio of documents relevant to the implementation of DIF-H. 
IDRC also provided information on the oversight of DIF-H. These documents offered 
valuable information about, and evidence of, DIF-H’s processes, finances, activities, outputs 
and outcomes. The documents that informed the evaluation findings are presented in the 
bibliography.  
Publically available academic and grey literature 
The external documents used to inform the findings of this evaluation are included in the 
bibliography. 
GCC Expert Review Panel discussions 
The GCC board of directors has commissioned a parallel review of GCC, to be conducted by 
a panel of international experts. The summative evaluation team leader met with the chair of 
the Expert Review Panel to discuss the panel’s findings. The evaluation team also read a 
preliminary draft copy of the Expert Review Panel report. The Panel’s findings were 
considered in this evaluation, where appropriate.  
Interviews and discussions with key informants and field-based case studies in Peru 
37 interviews and focus group discussions were held with key informants including: current 
and previous DIF-H consortium members, external experts, key stakeholders, and 
beneficiaries. These were conducted via telephone or in-person in Canada. 
The field visit to Peru involved meeting with and interviewing 7 GCC grantees and external 
stakeholders, and observing the activities of 2 DIF-H funded projects. For confidentiality 
reasons, the names of respondents are not reported.  
Data sources used to determine the results achieved by DIF-H (Core Issue 4)  
The following data sources were used to determine and report the results achieved by DIF-H 
(evaluation of Core Issue 4). The data sources presented above provided the context and 
background to these data, which was important for cross-checking and understanding the 
results. However, only the data sources listed below were used to determine the results 
achieved by DIF-H.  
Annual Letter 2015 
The Annual Letter 2015 was current as at May 2015. It provides approximated aggregated 
claims for lives saved and lives improved. No disaggregated data on individual grand 
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challenges or projects is given. It is included because it is the most recent official reporting of 
results that includes lives saved and lives improved.  
Annual Report 2013–2014 
The Annual Report 2013–2014 was current as at March 2014. It represents the officially 
released results of GCC. It contains results for 94 out of 537 of the grand challenge projects, 
disaggregated by grand challenge. However, lives saved and lives improved are not 
mentioned, only beneficiary access for Stars, SLAB, and Global Mental Health. Other 
outcomes and outputs are also reported. No individual project-level results or financial data 
are given. It is included because it is the most recent annual report.  
Results Dashboard 
The Results Dashboard is the most complete and recent set of results for the Stars, TTS, 
and Diagnostics grand challenges, current as at June 2015. As such, it reflects the most 
recent calculations of results for these portfolios. Aggregated results claims for ultimate and 
intermediate outcome indicators are included, as well as disaggregated results claims for the 
top performing projects. It also contains projections for lives saved and lives improved. 
However, it does not contain any results data for the other grand challenges, nor financial 
data for any projects. As an internal reporting document, it is considered by GCC to be a 
work in progress. 
Strategy Roadmap 
The Strategy Roadmap was current as of March 2015. It contains aggregated results claims 
for ultimate and intermediate outcomes for all grand challenges (except Hypertension and 
Explorations). However, the results claims in this document are only based on 299 of 654 
projects. Financial and funding data are provided which correspond to the aggregated grand 
challenge claims. Individual project-level data and results are not provided, but the Strategy 
Roadmap closely corresponds to the GCC project database where these data are provided.  
This is the only results document that corresponds to the GCC project database and financial 
reports, and is the most recent and complete set of results for all of the grand challenges. 
Therefore it is the most coherent and useful GCC results document.  
GCC project database 
The GCC project database was current as of March 2015, and closely corresponds to the 
Strategy Roadmap. It contains a full list of projects funded by GCC, alongside funding 
information. Originally the database contained some projects that were not in the Strategy 
Roadmap (USAID-managed SLAB projects, non-GCC-funded and unconfirmed TTS 
projects), but these were removed so that the project database matched the Strategy 
Roadmap (there is a discrepancy in respect of one SLAB project, but this is due to this 
project being re-classified as a TTS project).  
Additionally, GCC provided outcome statements, which are qualitative summaries of 
individual project results. The evaluators analyzed these statements and added the data 
provided to the corresponding project in the database. The outcome statements provide 
information on all grand challenges (except Hypertension and Explorations), but only for 245 
out of 653 projects. Furthermore, the statements did not provide data on all the possible 
results, and sometimes it was not possible to calculate the results achieved because of a 
lack of information: e.g. a project claims reduced mortality but population numbers are not 
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given so lives saved could not be determined. Where this occurred, the basis for these 
claims in the above results documents is unknown. 
Comparison of secondary data sources 
Table 11 shows the data sources, when they were current, and the total number of projects 
that were in the portfolio at this time. Table 12 presents the data sources by the number of 
projects that results claims are based upon. 
Table 11: Results sources by type of report, date when current, and number of 
projects in portfolio at this time.  





Roadmap    
(Current Mar-15) 






2015     
Annual Letter 
(Current May-15) 
Stars 471 471 471 392 x 
TTS 58 31 31 11 x 
Diagnostics 12 12 12 12 x 
Explorations x 6 6 6 x 
SLAB x 25 24*** 18**** x 
Saving Brains x 52 52 40 x 
Global Mental 
Health 
x 51 51 49 x 






541 654 653* 534** x 
‘x’ denotes that no information is given. 
* GCC supplied database with projects removed so that the database matches the Strategy 
Roadmap; 65 USAID-managed SLAB projects, six non-GCC funded TTS projects, and one 
TBD TTS project removed. The missing project is a double-counted SLAB project that 
appears in both the SLAB and TTS portfolios.  
 
** The total number of projects listed in the annual report (page 10) is 537 (538 minus the 
Global Health Investment Fund). However, this is an error: it should be 534. 
 
*** One SLAB project was mistakenly included in the Strategy Roadmap because it was 
reclassified as a TTS project. 
 
**** Only 18 of the SLAB projects are managed by GCC; the total number of SLAB projects 
managed by all partners is 61.  
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Table 12: Results sources by type of report, date when current, and number of 
projects that results claims are based upon 











2015     
Annual Letter 
(Current May-15) 
Stars 471 170 200 62 x 
TTS 58 16 2 0 x 
Diagnostics 12 12 12 0 x 
Explorations 0 0 0 0 x 
SLAB 0 24 10 24 x 
Saving Brains 0 26 13 0 x 
Global Mental 
Health 
0 51 8 8 x 




are based on 
541 299 245 94 x 
‘x’ denotes that no information is given. 
GCC grant applicant survey 
The GCC applicant survey was current as at late June 2015. It was developed by the 
evaluators, with input from IDRC and GCC. It was designed to capture self-reported data 
from GCC applicants and grantees. The information collected includes: demographic 
information on respondents; information related to respondents’ applications and funded 
projects; self-reported impacts, outcomes, and outputs and perceptions of the GCC 
application and grant management process.  
The survey was sent out to 2130 individuals who applied in response to GCC RFPs, and 
individuals who applied for USAID-administered SLAB RFPs that received grants from GCC. 
This is all the applicant email addresses provided by GCC once the email address list was 
cleaned. However, the total number of applications according to document 2.U (Application 
statistics across GCC programs) was 5609—although this may include applications to 
partner managed grants. Therefore the survey was sent to at least 40% of all applicants to 
GCC.  
The survey was open for two weeks and was available in English and French. The response 
rate was 31%, including emails that failed or were sent to the wrong person. The completion 
rate was 81%. The response and completion rate for GCC-funded applicants was much 
higher than for respondents whose application(s) were rejected. 
A total of 664 surveys were completed. This included: 361 responses from applicants that 
were funded by GCC (approximately half of all GCC grantees); 68 responses from applicants 
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that were rejected by GCC but whose projects were subsequently funded through another 
source; and 169 responses from applicants who were rejected by GCC and whose projects 
were not subsequently funded. The remaining 66 respondents did not provide funding 
information.  
Figure 6: Graphical representation of the geographical distribution of respondents 
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D. Case study 1: Rapid syphilis tests as a catalyst for health system 
strengthening: a case study from Peru 
Mother-to-child transmission of syphilis continues to be a public health problem and represents an 
easily treatable cause of negative birth outcomes. Globally, it is estimated that approximately 2 
million pregnancies each year involve women with syphilis (McDermott, Sketee and Larsen, 1993). 
Untreated syphilis can lead to fetal loss or still-birth. In live-born infants it can lead to neonatal 
death, prematurity, low birth weight or congenital syphilis. In pregnant women infected with 
syphilis, adverse birth outcomes are common and have been shown to be 4.5 times higher in 
untreated women compared to women without the disease (Claire Bristow, Oxford University 
2014). Yet, the treatment is simple: a single dose of penicillin before 28 weeks gestation prevents 
these adverse outcomes.  
In 2010, the WHO called for the dual elimination of mother-to-child-transmission of HIV and 
syphilis with new strategies and integrated monitoring and evaluation activities (WHO, 2013a; Pan 
American Health Organization, 2010). Until recently however, diagnostic tests were not available in 
Peru (Dinh et al., 2013). Numerous barriers have been identified which limit the effective screening 
and treatment of pregnant women, including lack of tests at health facilities, cost of screening, and 
delays in providing test results (Garcia et al., 2013).  
What was the proof-of-concept and how did it respond to the integrated innovation 
principles?  
An innovator from the Cayetano Heredia University in Lima, Professor Patricia Garcia, submitted a 
proposal to GCC to fund operational research that would distribute rapid dual HIV and syphilis 
tests to rural communities in Peru. The project, Brighter Futures, aimed to determine the 
acceptance and effectiveness of the rapid test. 
Prof. Garcia was trying to prove that the dual HIV and syphilis test, which is recommended by 
WHO but not used in many countries (in 2010 there was evidence of the policy implementation 
only in Haiti), was effective and positively accepted by communities. The innovation was not the 
invention of the diagnostic tool itself but rather finding a way to address the implementation gap 
that was hindering the implementation of an international evidence-based guideline. Prof. Garcia’s 
approach was an implementation of integrated innovation. It proposed testing a comprehensive 
model, from the acceptance of the patients all the way to accessing the treatment drug once test 
results were available.  
The direct impact of DIF-H-funded intervention  
During the pilot phase funded by the project, 2,798 women were screened and referred for 
treatment for HIV, syphilis and anemia. These patients had access to a new service and may have 
had their life considerably improved, without counting the future infections this avoided. The project 
also trained 514 formal and informal health care providers to administer the tests.  
The research created new localized knowledge, and supported a policy change. It concluded that 
the test was effective and well accepted in Peru. Prof. Garcia published two papers in peer-
reviewed journals and has an additional five in press. This project enabled her to make a case to 
the Ministry of Health; today in Peru, dual HIV and syphilis tests have become part of the antenatal 
care (ANC) protocol. Since 2015 a new line was added to the Ministry of Health budget to ensure 
the required resources are allocated to continue implementing this policy. It is estimated that there 
are 800,000 pregnant women per year in Peru and ANC coverage is 98%. With a mandatory dual 
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test during ANC it is reasonable to estimate that there are now about 784,000 pregnant women are 
screened each year for HIV and syphilis in the country.  
Brighter Futures went beyond these impacts 
The project was instrumental in changing national procurement processes to be more effective, 
and resulted in a partnership between the Ministry of Health and the United Nations Children’s 
Fund (UNICEF). The project was designed according to a service delivery and health system 
strengthening approach, to ensure a continuum of care. The partnership with the Ministry of Health 
ensured penicillin was available in the case of a positive diagnosis, thereby avoiding losing contact 
with the patient between the diagnostic result and treatment. A pharmacy model that links the 
diagnostic directly with the treatment drug has been adopted and is scaling up through one of the 
main pharmacy chains in Peru (Boticas Arcangel).  
Finally, this intervention enabled two further valuable changes. Firstly, it changed the behaviour of 
Peruvians toward rapid tests, with which there had been a legacy of negative experiences, 
resulting in reluctance within the national health system to use these diagnostic instruments. 
Secondly, the training of informal health workers not only enabled a faster scale-up of the test 
administration, but also had a positive impact on the position and recognition of informal health 
workers in the country, where there is little consideration of, and willingness to work with, untrained 
health staff.  
Brighter Futures’ budget was $940,022. The table below details the final project results and 
outputs and respective costs20. However, this does not account for the potential future impacts of 
the project.  
Results and outputs  Cost in C$ 
Cost per publication (counting five publications) 188,004 
Cost for policy change (counting three policy changes) 313,341 
Cost per women screened and referred for treatment for HIV, syphilis and 
anemia (2,798) 
336 
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E. Case study 2: Saving Brains, Leonid Lecca, HPI and Socios en Salud: 
The Casitas project  
Maribel Muniz, a GCC grantee, believes that ‘tiny smiles make big changes’. With a grant from 
GCC, she is trying to measure the positive impact of those smiles, and she is getting impressive 
results. 
 
There is an international consensus regarding the importance of providing good care for children: 
all children need to be cared for, especially children suffering from neurodevelopment delays 
(NDD). Unconventional research also demonstrates that this does not only include access to basic 
needs – appropriate food (in quality and quantity), health, education, etc. – it also includes 
tenderness, love, and attention. This type of research usually has less traction with funders: its 
findings represent no economic interest and yet it has significant potential to improve lives.  
 
Casitas is a project in Peru, implemented by Socios en Salud. With less than C$100,000 a team of 
community health and social workers are taking time to visit young parents to explain the 
importance of giving their children tenderness and attention. The project attempts to measure, both 
qualitatively and quantitatively, the impact of this love and care on the children. It also aims to 
provide evidence of the efficacy of a community-based intervention, improve parenting behaviour 
to support child development and reduce NDD among children in low resource settings.  
 
The project manager told us that before GCC, Socios en Salud was focused on clinical research. 
GCC was the first funder that was interested in funding the intervention as a research and 
implementation project, and it was truly interested in the implementation component and was 
flexible enough to allow it to be responsive to the realities found on the ground. 
 
The project focuses on children with NDD and aims to demonstrate the feasibility and the efficacy 
of a community-level intervention to reduce NDD among children in vulnerable and poor 
neighbourhoods. A target population was defined and split into three intervention arms: to one 
group the intervention provided nutritional support; to the second group the intervention provided 
nutritional support and the community-based intervention delivered at home on a one-to-one basis; 
the third group also had the nutritional support but the community-based intervention was delivered 
in groups. In fact, all of the household children and the parents benefited from the intervention.  
 
Preliminary findings suggest that ensuring children are cared for with tenderness and attention has 
a measurable impact on their growth, compared to those that only receive nutritional support. Tiny 
smiles seem to not only change the families and communities, they also improve children’s growth. 
These findings are powerful. With these results, Casitas was able to mobilize the municipality 
where the pilot is being conducted, a poor neighbourhood of northern Lima, to scale the 
intervention up in partnership with the public sector. Casitas is also working in close relationship 
with the Partners in Health Network, mainly in Rwanda and Haiti, to replicate the experience. 
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• Lives saved 




• Increased use of innovative health products/services by target 
population 
• Increased use of innovative health products/services by families, 




• Increased access to innovative health products and/or services by 
target populations in developing countries 
• Increased adoption of innovative health policies, regulations, or 
legislation contributing to solving global challenges in developing 
countries 
• Increased jobs created related to innovative health products and/or 
services in developing countries 
• Increased knowledge and awareness of positive international 
Canada brand 
• Improved development innovation platform in Canada  
Outputs 
• Innovative prototypes or service delivery models developed and/or 
scaled 
• Targeted challenge-specific outcome metrics developed 
• Private sector engaged 
• Canada brand awareness raised 
• Lessons learned and outcomes monitored and evaluated 
• Results published and patents filed 
• Targeted challenge-specific global partnerships formed 
• Targeted challenge-specific communities of innovators formed 
• Funds leveraged by projects 
• Canadian diplomacy enabled 
• Grand challenge model adopted and enhanced 
• Risks managed 
• Efficient operating model maintained 
 
